GLP-1 Market
LLY $1157.49 ▲ +1.3% NVO $37.53 ▼ -0.0% PFE $27.50 ▲ +0.3% VKTX $28.38 ▼ -3.1% KLRA $10.83 ▼ -0.1% GPCR $27.47 ▼ -0.4% RHHBY $52.55 ▲ +0.1%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Busulfan

Company
St. Jude Children's Research Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
91 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

91 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 7, 2026

Find a Clinical Trial Near Me

See recruiting studies for Busulfan and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01306019

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 40 participants Est. completion 2032-12-31 1 site
    Other conditions: X-linked Severe Combined Immunodeficiency (XSCID)
    View official trial listing →
  • Recruiting NCT NCT01666080

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

    Not yet reported Masonic Cancer Center, University of Minnesota 30 participants Est. completion 2028-06 1 site
    Other conditions: Hematologic Disorders, Hemoglobinopathies, Immunodeficiencies
    View official trial listing →
  • Recruiting NCT NCT01861106

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

    Not yet reported National Cancer Institute (NCI) 144 participants Est. completion 2028-12-31 1 site
    Other conditions: GATA2, Immunodeficiency, MDS
    View official trial listing →
  • Recruiting NCT NCT01949129

    Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

    Not yet reported, Not yet reported St. Anna Kinderkrebsforschung 1800 participants Est. completion 2030-06-01 119 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukaemia
    View official trial listing →
  • Recruiting NCT NCT02143830

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

    Not yet reported Children's Hospital Medical Center, Cincinnati 70 participants Est. completion 2028-12 3 sites Stand-alone
    Other conditions: Fanconi Anemia, Severe Marrow Failure, Myelodysplastic Syndrome (MDS), Acute Myelogenous Leukemia (AML)
    View official trial listing →
  • Recruiting NCT NCT02579967

    Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

    Not yet reported National Cancer Institute (NCI) 354 participants Est. completion 2036-12-31 2 sites Stand-alone
    Other conditions: Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases, Autoimmune Lymphoproliferative, Lymphoproliferative Disorders
    View official trial listing →
  • Recruiting NCT NCT02727803

    Personalized NK Cell Therapy in CBT

    Not yet reported M.D. Anderson Cancer Center 100 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Acute Myeloid Leukemia With Variant MLL Translocations, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Chemotherapy-Related Leukemia, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, ISS Stage II Plasma Cell Myeloma, ISS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Myelodysplastic Syndrome With Gene Mutation, Myelodysplastic/Myeloproliferative Neoplasm, Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Adult Acute Lymphoblastic Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT02859402

    Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

    Not yet reported Keimyung University Dongsan Medical Center 34 participants Est. completion 2027-12 2 sites Stand-alone
    Other conditions: T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell
    View official trial listing →
  • Recruiting NCT NCT03016806

    Umbilical Cord Blood Transplantation From Unrelated Donors

    University of Rochester 30 participants Est. completion 2027-06 1 site
    Other conditions: Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder, Metabolism Disorder, Aplastic Anemia, Myelodysplastic Syndromes, Chronic Leukemia, Lymphoma, Multiple Myeloma, Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT03126916

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

    Not yet reported Children's Oncology Group 750 participants Est. completion 2030-09-30 164 sites Stand-alone
    Other conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma
    View official trial listing →
  • Recruiting NCT NCT03311503

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

    Not yet reported, Not yet reported David Williams 12 participants Est. completion 2028-01-01 4 sites
    Other conditions: Severe Combined Immunodeficiency, X Linked, Gene Therapy
    View official trial listing →
  • Recruiting NCT NCT03314974

    Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

    Not yet reported Masonic Cancer Center, University of Minnesota 300 participants Est. completion 2028-06-10 1 site Stand-alone
    Other conditions: Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myeloproliferative Neoplasms, Myelofibrosis, Myelodysplasia, Refractory Anemia, High Risk Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Diffuse Large Cell Non Hodgkins Lymphoma, Lymphoblastic Lymphoma, Burkitt Lymphoma, High Grade Non-Hodgkin's Lymphoma, Adult, Multiple Myeloma, Juvenile Myelomonocytic Leukemia, Biphenotypic/Undifferentiated/Prolymphocytic Leukemias, MRD Positive Leukemia, Natural Killer Cell Malignancies, Acquired Bone Marrow Failure Syndromes
    View official trial listing →
  • Recruiting NCT NCT03509961

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

    Not yet reported Pediatric Transplantation & Cellular Therapy Consortium 95 participants Est. completion 2026-07-01 24 sites
    Other conditions: B-cell Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT03538899

    Autologous Gene Therapy for Artemis-Deficient SCID

    Not yet reported, Not yet reported University of California, San Francisco 24 participants Est. completion 2038-06 1 site Stand-alone
    Other conditions: Severe Combined Immunodeficiency
    View official trial listing →
  • Recruiting NCT NCT03579875

    Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

    Not yet reported Masonic Cancer Center, University of Minnesota 48 participants Est. completion 2029-01-05 1 site Stand-alone
    Other conditions: Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes, T Cell Receptor Alpha/Beta Depletion, Telomere Biology Disorder, Bone Marrow Failure, Dyskeratosis Congenita, Telomere Biology Disorders
    View official trial listing →
  • Recruiting NCT NCT03793517

    Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

    Not yet reported, Not yet reported Peking University People's Hospital 55 participants Est. completion 2026-10 1 site Stand-alone
    Other conditions: Stem Cell Transplant Complications, Leukemia, Myeloid, Acute, Leukemia Relapse
    View official trial listing →
  • Recruiting NCT NCT03810196

    CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

    Not yet reported Children's Hospital of Philadelphia 50 participants Est. completion 2028-07 1 site
    Other conditions: Acute Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Mixed Lineage Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma, Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT03970096

    Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

    Not yet reported Fred Hutchinson Cancer Center 120 participants Est. completion 2029-12-31 3 sites Stand-alone
    Other conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04221035

    High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 800 participants Est. completion 2032-11 142 sites Stand-alone
    Other conditions: High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
    View official trial listing →
  • Recruiting NCT NCT04314219

    Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

    Not yet reported King Faisal Specialist Hospital & Research Center 264 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in Remission
    View official trial listing →
  • Recruiting NCT NCT04339777

    Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2027-11-30 1 site
    Other conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases, Common Variable Immunodeficiency, Primary T-cell Immunodeficiency Disorders
    View official trial listing →
  • Recruiting NCT NCT04644016

    Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

    Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2026-12-20 1 site Stand-alone
    Other conditions: AML, ALL, MDS, MPD Withou Myelofibrosis, NHL or HL, Inherited Metabolic Disorders, Hemoglobinopathies, Bone Marrow Failure, HLH
    View official trial listing →
  • Recruiting NCT NCT04708054

    Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 324 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT04774536

    Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

    Not yet reported, Not yet reported Mark Walters, MD 9 participants Est. completion 2030-03-01 2 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT05027945

    A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

    Not yet reported National Cancer Institute (NCI) 54 participants Est. completion 2031-07-01 1 site Stand-alone
    Other conditions: Immunodeficiency, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05088226

    Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen

    Not yet reported Chinese PLA General Hospital 50 participants Est. completion 2031-06-01 1 site Stand-alone
    Other conditions: Peripheral Blood Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05327023

    Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

    Not yet reported, Not yet reported National Cancer Institute (NCI) 430 participants Est. completion 2029-07-02 1 site Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT05427136

    Early Pulmonary Dysfunction in Childhood Cancer Patients

    University Children's Hospital Basel 140 participants Est. completion 2051-06 5 sites
    Other conditions: Pulmonary Dysfunction
    View official trial listing →
  • Recruiting NCT NCT05436561

    Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies

    Not yet reported Shanghai Jiao Tong University School of Medicine 61 participants Est. completion 2027-06-30 2 sites Stand-alone
    Other conditions: Disease-free Survival
    View official trial listing →
  • Recruiting NCT NCT05463133

    Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2032-12-31 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Recruiting NCT NCT05467189

    Antineoplastic Drugs in Elderly Patients

    Shandong University 500 participants Est. completion 2028-06-30 1 site
    Other conditions: Cancer
    View official trial listing →
  • Recruiting NCT NCT05470491

    Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

    Not yet reported, Not yet reported National Cancer Institute (NCI) 265 participants Est. completion 2028-07-30 1 site Stand-alone
    Other conditions: HIV, Hematologic Malignancies
    View official trial listing →
  • Recruiting NCT NCT05477563

    Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

    Not yet reported Vertex Pharmaceuticals Incorporated 26 participants Est. completion 2027-06-09 6 sites Stand-alone
    Other conditions: Beta-Thalassemia, Thalassemia, Hematologic Diseases, Genetic Diseases, Inborn, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Anemia
    View official trial listing →
  • Recruiting NCT NCT05477589

    Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

    Not yet reported Vastra Gotaland Region 170 participants Est. completion 2031-12-31 17 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05564390

    MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

    Not yet reported National Cancer Institute (NCI) 2000 participants Est. completion 2029-05-15 354 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia, Myelodysplasia-Related, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT05711732

    Busulfan Sample Collection Study

    Saladax Biomedical, Inc. 150 participants Est. completion 2027-04-30 3 sites
    Other conditions: Subjects Treated With Busulfan
    View official trial listing →
  • Recruiting NCT NCT05735717

    MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

    Not yet reported Masonic Cancer Center, University of Minnesota 70 participants Est. completion 2030-11-30 1 site Stand-alone
    Other conditions: Hematologic Malignancy, Acute Leukemia, Remission, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, AML, TP53, Intrachromosomal Amplification of Chromosome 21, Cytogenetic Abnormality, CNS Leukemia, Minimal Residual Disease, Myelodysplasia, Juvenile Myelomonocytic Leukemia, Somatic Mutation, PTPN11 Gene Mutation, N-RAS Gene Amplification, Neurofibromatosis 1, NF1 Mutation, CBL Gene Mutation, Monosomy 7, Chromosome Abnormality, Fetal Hemoglobin, Lymphoblastic Lymphoma, High Grade Non-Hodgkin's Lymphoma, Adult
    View official trial listing →
  • Recruiting NCT NCT05762510

    A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]

    Not yet reported First Affiliated Hospital of Guangxi Medical University 5 participants Est. completion 2030-10-31 1 site Stand-alone
    Other conditions: Transfusion Dependent Beta-Thalassemia
    View official trial listing →
  • Recruiting NCT NCT05870995

    Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia

    Not yet reported Shanghai Jiao Tong University School of Medicine 100 participants Est. completion 2026-09-01 3 sites Stand-alone
    Other conditions: Refractory Leukemia
    View official trial listing →
  • Recruiting NCT NCT05917405

    Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

    Not yet reported Nantes University Hospital 302 participants Est. completion 2028-09-14 23 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia in Remission
    View official trial listing →
  • Recruiting NCT NCT05991908

    Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

    Not yet reported Shanghai Jiao Tong University School of Medicine 222 participants Est. completion 2026-06-30 9 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT06107400

    Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease

    Not yet reported The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army 5 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases
    View official trial listing →
  • Recruiting NCT NCT06111612

    Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50 participants Est. completion 2027-01-01 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Neoplasm, Chronic Myelomonocytic Leukemia, Myeloid Sarcoma, Extramedullary Myeloid Tumor
    View official trial listing →
  • Recruiting NCT NCT06125483

    TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT

    Not yet reported The First Affiliated Hospital of Soochow University 38 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT06155188

    Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

    Not yet reported Nanfang Hospital, Southern Medical University 60 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Leukemia, Stem Cell Transplant, Cord Blood
    View official trial listing →
  • Recruiting NCT NCT06158828

    Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

    Not yet reported, Not yet reported Washington University School of Medicine 68 participants Est. completion 2030-05-31 1 site Stand-alone
    Other conditions: AML, Childhood, Aml, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06207799

    Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

    Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2031-12-31 1 site Stand-alone
    Other conditions: Multiple Myeloma, Post-transplant MRD-guided Maintenance Therapy, Pre-transplant Purging
    View official trial listing →
  • Recruiting NCT NCT06219239

    Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 3 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Transfusion-dependent Beta-Thalassemia
    View official trial listing →
  • Recruiting NCT NCT06252870

    Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

    Not yet reported Nantes University Hospital 82 participants Est. completion 2028-07-18 3 sites
    Other conditions: Graft Versus Host Disease, Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT06280378

    Β-Thalassemia Treatment with KL003 Cell Injection

    Not yet reported, Not yet reported Kanglin Biotechnology (Hangzhou) Co., Ltd. 41 participants Est. completion 2027-05 2 sites Stand-alone
    Other conditions: Transfusion-dependent Beta-Thalassemia
    View official trial listing →
  • Recruiting NCT NCT06315309

    Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

    Not yet reported University of Alabama at Birmingham 29 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: GVHD,Acute, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
    View official trial listing →
  • Recruiting NCT NCT06325709

    Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2032-12-31 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease
    View official trial listing →
  • Recruiting NCT NCT06345495

    High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

    Not yet reported M.D. Anderson Cancer Center 30 participants Est. completion 2029-01-01 1 site Stand-alone
    Other conditions: Splenomegaly, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06364774

    ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

    Not yet reported, Not yet reported Children's Hospital of Philadelphia 12 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Beta-Thalassemia
    View official trial listing →
  • Recruiting NCT NCT06399107

    Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease

    Not yet reported, Not yet reported Essen Biotech 85 participants Est. completion 2025-12-28 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Sickle-Cell Disease With Crisis
    View official trial listing →
  • Recruiting NCT NCT06477549

    BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

    Not yet reported St. Petersburg State Pavlov Medical University 220 participants Est. completion 2029-06 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, Lymphoblastic Lymphoma, Myeloproliferative Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT06506461

    Gene Editing For Sickle Cell Disease

    Not yet reported St. Jude Children's Research Hospital 25 participants Est. completion 2032-12 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT06548958

    A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases

    Not yet reported The First Affiliated Hospital of Soochow University 40 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Malignant Hematological Diseases
    View official trial listing →
  • Recruiting NCT NCT06571825

    RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

    Not yet reported He Huang 118 participants Est. completion 2028-02-28 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06674382

    Haplo-HSCT for Myelofibrosis

    Not yet reported Peking University People's Hospital 39 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06802315

    Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

    Not yet reported University of Illinois at Chicago 38 participants Est. completion 2032-03 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Relapsed, Adult, Acute Myeloid Leukemia Refractory, Chronic Myeloid Leukemia - Accelerated Phase, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT06809699

    Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported He Huang 29 participants Est. completion 2027-10-31 1 site Stand-alone
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Recruiting NCT NCT06809712

    Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported He Huang 29 participants Est. completion 2027-10-31 1 site Stand-alone
    Other conditions: Hematologic Disease
    View official trial listing →
  • Recruiting NCT NCT06816134

    Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

    Not yet reported The First Affiliated Hospital of Soochow University 48 participants Est. completion 2030-01-30 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell, Conditioning Therapy
    View official trial listing →
  • Recruiting NCT NCT06829472

    Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan

    Not yet reported Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2026-12-01 2 sites Stand-alone
    Other conditions: Toxicities, Survivorship
    View official trial listing →
  • Recruiting NCT NCT06830421

    Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

    Not yet reported University Hospital Freiburg 340 participants Est. completion 2031-08-31 35 sites Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06859424

    A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Center for International Blood and Marrow Transplant Research 358 participants Est. completion 2028-06 13 sites Stand-alone
    Other conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06869265

    Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

    Not yet reported Peking University People's Hospital 56 participants Est. completion 2029-04-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), High Risk Acute Myeloid Leukemia(AML), Relapsed/Refractory Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Recruiting NCT NCT06872333

    Allo HSCT for High Risk Hemoglobinopathies

    Not yet reported Masonic Cancer Center, University of Minnesota 62 participants Est. completion 2032-06-01 1 site Stand-alone
    Other conditions: Graft Failure, Sickle Cell Disease, Hemoglobinopathies
    View official trial listing →
  • Recruiting NCT NCT06879847

    A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML

    Not yet reported The First Affiliated Hospital of Soochow University 40 participants Est. completion 2027-11-30 1 site Stand-alone
    Other conditions: Relapsed or Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06959771

    Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1 participants Est. completion 2027-10-28 1 site Stand-alone
    Other conditions: CD40L-HyperIgM Syndrome
    View official trial listing →
  • Recruiting NCT NCT06984536

    Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT

    Not yet reported Peking University People's Hospital 40 participants Est. completion 2026-07-31 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Acute Leukemia
    View official trial listing →
  • Recruiting NCT NCT06996119

    Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

    Not yet reported City of Hope Medical Center 15 participants Est. completion 2027-05-25 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Graft Versus Host Disease, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT07014943

    High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma

    Not yet reported Sichuan University 34 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL)
    View official trial listing →
  • Recruiting NCT NCT07059741

    Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

    Not yet reported The First Affiliated Hospital of Soochow University 20 participants Est. completion 2028-12-10 1 site Stand-alone
    Other conditions: Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
    View official trial listing →
  • Recruiting NCT NCT07074470

    Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL

    Not yet reported The First Affiliated Hospital of Soochow University 40 participants Est. completion 2032-01-02 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL)
    View official trial listing →
  • Recruiting NCT NCT07101588

    Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

    Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2028-12-30 1 site
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    View official trial listing →
  • Recruiting NCT NCT07108530

    Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study

    Not yet reported Shanxi Bethune Hospital 50 participants Est. completion 2027-08-06 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07183878

    Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

    Not yet reported First Affiliated Hospital of Zhejiang University 138 participants Est. completion 2028-08-20 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndromes, High-Risk Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT07228624

    Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

    Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2030-09-01 1 site Stand-alone
    Other conditions: Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT07373639

    A Long-term Follow-up Study in Patients Who Received BEAM-101

    Beam Therapeutics Inc. 50 participants Est. completion 2043-02-12 17 sites
    Other conditions: Hemoglobinopathy, Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT07499284

    A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

    Not yet reported The First Affiliated Hospital of Soochow University 224 participants Est. completion 2028-09-30 4 sites Stand-alone
    Other conditions: Aplastic Anaemia
    View official trial listing →
  • Recruiting NCT NCT07500753

    A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients

    Not yet reported The First Affiliated Hospital of Soochow University 30 participants Est. completion 2029-06-30 1 site Stand-alone
    Other conditions: Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)
    View official trial listing →
  • Recruiting NCT NCT07532824

    Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

    Not yet reported, Not yet reported Institute of Hematology and Blood Transfusion, Czech Republic 16 participants Est. completion 2029-11 2 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML, Proton Therapy, MDS and AML Prior to Allogeneic SCT, Myelodysplastic Neoplasm
    View official trial listing →
  • Recruiting NCT NCT07565220

    Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

    Not yet reported Sawa Ito, MD 48 participants Est. completion 2030-11-01 1 site Stand-alone
    Other conditions: Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Acute Leukemia, Myelodysplastic Syndrome(MDS), Myeloproliferative Neoplasm (MPN)
    View official trial listing →
  • Recruiting NCT NCT07566377

    Cord Blood Transplantation in Children and Young Adults With Blood Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 71 participants Est. completion 2030-04-28 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease
    View official trial listing →
  • Recruiting NCT NCT07583888

    VABu Conditioning in Elderly AML HSCT

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 20 participants Est. completion 2027-08-15 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Recruiting NCT NCT07586735

    A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA

    Peking University People's Hospital 64 participants Est. completion 2029-12-30 1 site
    Other conditions: Severe Aplastic Anemia, Aplastic Anaemia, Hematopoietic Cell Transplant
    View official trial listing →
  • Recruiting NCT NCT07588360

    Haplo-Cord HSCT for AML/MDS

    Not yet reported Fujian Medical University Union Hospital 82 participants Est. completion 2029-06-30 4 sites Stand-alone
    Other conditions: MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia)
    View official trial listing →
  • Recruiting NCT NCT07588594

    Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

    Not yet reported Peking University People's Hospital 31 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Chronic Myelomonocytic Leukemia (CMML)
    View official trial listing →
  • Recruiting NCT NCT07677306

    Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT

    Not yet reported Peking University People's Hospital 120 participants Est. completion 2028-06-30 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00002502

    Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2000-05 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00002547

    Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

    Not yet reported Barbara Ann Karmanos Cancer Institute 280 participants Est. completion 2003-10 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00002549

    Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1520 participants 75 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002554

    Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

    Not yet reported Fred Hutchinson Cancer Center 30 participants Est. completion 1999-12
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002592

    Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported Abramson Cancer Center at Penn Medicine 40 participants Est. completion 2002-08 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00002701

    Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 750 participants 71 sites
    Other conditions: Leukemia
    View official trial listing →
  • Withdrawn NCT NCT00002761

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported, Not yet reported Columbia University Est. completion 2007-10
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002768

    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission

    Not yet reported Alliance for Clinical Trials in Oncology 51 participants Est. completion 2009-03 3 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00002771

    Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported German CML Study Group 750 participants 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002789

    Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia

    Not yet reported Fred Hutchinson Cancer Center 100 participants Est. completion 2001-09 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002792

    Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2003-04 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00002798

    Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not yet reported National Cancer Institute (NCI) 880 participants 1 site Stand-alone
    Other conditions: Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Ringed Sideroblasts, Secondary Myelodysplastic Syndromes, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    View official trial listing →
  • Completed NCT NCT00002831

    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2002-12-31 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002868

    Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

    Not yet reported Eastern Cooperative Oncology Group 744 participants 3 sites
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00002961

    Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia

    Not yet reported Children's Hospital of Philadelphia 43 participants Est. completion 2001-02 18 sites
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00002989

    Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 207 participants 9 sites
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00003060

    Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

    Not yet reported Louisiana State University Health Sciences Center Shreveport 6 participants Est. completion 2001-02-22 1 site
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00003081

    Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

    Not yet reported Fred Hutchinson Cancer Center 16 participants Est. completion 2002-01 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00003101

    Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

    Not yet reported Memorial Sloan Kettering Cancer Center 60 participants Est. completion 2002-01 7 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00003116

    High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Case Comprehensive Cancer Center 66 participants Est. completion 2009-06 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003146

    Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-06 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003195

    Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2000-11 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003199

    Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003270

    Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Roswell Park Cancer Institute 20 participants Est. completion 2017-10-16 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00003335

    Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

    Not yet reported Case Comprehensive Cancer Center 44 participants Est. completion 2012-01 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003336

    Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

    Not yet reported Case Comprehensive Cancer Center 6 participants Est. completion 2006-02 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003414

    Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50 participants Est. completion 2004-05 1 site
    Other conditions: Graft Versus Host Disease, Lymphoma
    View official trial listing →
  • Completed NCT NCT00003462

    Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors

    Not yet reported Duke University 20 participants Est. completion 2001-02 1 site
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00003619

    Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

    Not yet reported, Not yet reported Drexel University College of Medicine Est. completion 2004-04 2 sites
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00003661

    Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Roswell Park Cancer Institute 3 participants Est. completion 2006-03 17 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00003662

    Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

    Not yet reported Roswell Park Cancer Institute 90 participants Est. completion 2001-01 15 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Thymic Carcinoma
    View official trial listing →
  • Completed NCT NCT00003816

    Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

    Not yet reported, Not yet reported Roswell Park Cancer Institute 361 participants Est. completion 2019-07-12 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Nonmalignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00003875

    Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia

    Not yet reported Fred Hutchinson Cancer Center 30 participants Est. completion 2015-06-11 1 site Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Childhood Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00003913

    Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

    Not yet reported Fred Hutchinson Cancer Center 390 participants Est. completion 2005-08 23 sites
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT00003926

    Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

    Not yet reported Masonic Cancer Center, University of Minnesota 13 participants Est. completion 2003-08 1 site Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Chordoma, Kidney Cancer, Liver Cancer, Neuroblastoma, Ovarian Cancer, Retinoblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00003960

    Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36 participants Est. completion 2001-09 2 sites
    Other conditions: Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00003972

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 280 participants Est. completion 2003-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004088

    Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

    Not yet reported City of Hope Medical Center 77 participants Est. completion 2018-01-09 2 sites Stand-alone
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Status unknown NCT NCT00004128

    Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 2000 participants
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00004171

    Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma

    Not yet reported Northwestern University Est. completion 2002-06 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00004181

    Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia

    Not yet reported Northwestern University Est. completion 2004-08 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00004231

    Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

    Not yet reported Northwestern University Est. completion 2006-08 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00004896

    Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not yet reported Northwestern University Est. completion 2004-08 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00004899

    Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not yet reported Northwestern University Est. completion 2004-08 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00004907

    Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Northwestern University Est. completion 2004-08 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00005641

    Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2000-09 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005797

    Bone Marrow Transplant in Treating Patients With Hematologic Cancers

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 125 participants Est. completion 2007-07 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00005824

    Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma

    Not yet reported AIDS Malignancy Consortium Est. completion 2006-04 2 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00005866

    S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

    Not yet reported SWOG Cancer Research Network 240 participants Est. completion 2006-03 66 sites Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005893

    Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders

    Not yet reported Fairview University Medical Center 1 site
    Other conditions: Neutropenia, Sickle Cell Anemia, Thalassemia Major, Red-Cell Aplasia, Pure
    View official trial listing →
  • Completed NCT NCT00005940

    Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission

    Not yet reported Fred Hutchinson Cancer Center 18 participants 3 sites Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
    View official trial listing →
  • Completed NCT NCT00005948

    Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-10 2 sites
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00005986

    Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00006054

    Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

    Not yet reported Fairview University Medical Center Est. completion 2002-12 1 site
    Other conditions: Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency, Graft Versus Host Disease, X-Linked Lymphoproliferative Syndrome, Familial Erythrophagocytic Lymphohistiocytosis, Hemophagocytic Lymphohistiocytosis, X-linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, X-linked Hyper IgM Syndrome, Severe Combined Immunodeficiency, Leukocyte Adhesion Deficiency Syndrome, Virus-Associated Hemophagocytic Syndrome
    View official trial listing →
  • Status unknown NCT NCT00006056

    Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

    Not yet reported Fairview University Medical Center 40 participants 1 site
    Other conditions: Chediak-Higashi Syndrome, Graft Versus Host Disease, X-Linked Lymphoproliferative Syndrome, Familial Erythrophagocytic Lymphohistiocytosis, Hemophagocytic Lymphohistiocytosis, Virus-Associated Hemophagocytic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT00006126

    Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

    Not yet reported Northwestern University Est. completion 2001-04
    Other conditions: Breast Cancer, Kidney Cancer, Lung Cancer, Melanoma (Skin), Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00006246

    Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

    Not yet reported Pediatric Brain Tumor Consortium 28 participants 8 sites
    Other conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Leukemia, Lymphoma, Metastatic Cancer, Retinoblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00006363

    Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 720 participants 1 site Stand-alone
    Other conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    View official trial listing →
  • Completed NCT NCT00006367

    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2004-01 9 sites
    Other conditions: Chronic Myeloproliferative Disorders
    View official trial listing →
  • Completed NCT NCT00007995

    Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

    Not yet reported Herbert Irving Comprehensive Cancer Center 75 participants Est. completion 2008-05 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00008190

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia

    Not yet reported Herbert Irving Comprehensive Cancer Center Est. completion 2008-05 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00014469

    Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2007-05 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00020566

    Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

    Not yet reported University of Leicester 1200 participants 103 sites Stand-alone
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00024050

    Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2007-08 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00024193

    Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma

    Not yet reported Children's Cancer and Leukaemia Group 1 site
    Other conditions: Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT00025402

    Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported III. Medizinische Klinik Mannheim 1000 participants 188 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00025649

    Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma

    Not yet reported European Infant Neuroblastoma Study Group - 1999 Est. completion 2009-03 11 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00027924

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2003-05 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00027937

    Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2007-11 1 site
    Other conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00029380

    Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 30 participants Est. completion 2006-08 15 sites
    Other conditions: Hematologic Diseases, Anemia, Sickle Cell, Beta-Thalassemia, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT00030719

    Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma

    Not yet reported University of Leicester 175 participants 32 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00034528

    Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2003-11 1 site Stand-alone
    Other conditions: Hemoglobinopathies, Anemia, Sickle Cell, Hemoglobin SC Disease, Thalassemia, Thalassemia Major
    View official trial listing →
  • Terminated NCT NCT00040469

    Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies

    Not yet reported Baylor College of Medicine 15 participants Est. completion 2003-11-21 2 sites
    Other conditions: Sickle Cell Anemia, Hemoglobinopathy, Thalassemia
    View official trial listing →
  • Terminated NCT NCT00043810

    Study of Gelonin Purging of Autologous Stem Cells for Transplantation

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2005-03 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00049517

    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

    Not yet reported Eastern Cooperative Oncology Group 657 participants Est. completion 2019-12 99 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00049634

    Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 30 participants 2 sites
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00053196

    Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 82 participants Est. completion 2010-08 12 sites Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00054327

    Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Not yet reported Case Comprehensive Cancer Center 34 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00054340

    Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2006-09 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00055653

    Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

    Not yet reported Roswell Park Cancer Institute Est. completion 2005-09 25 sites
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00060255

    High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

    Not yet reported Roswell Park Cancer Institute 451 participants Est. completion 2013-02 1 site
    Other conditions: Breast Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00070135

    Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

    Not yet reported Alliance for Clinical Trials in Oncology 121 participants Est. completion 2016-06-15 21 sites Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00070174

    Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy

    Not yet reported Children's Oncology Group 350 participants Est. completion 2013-12 148 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00077116

    Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 31 participants 9 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Withdrawn NCT NCT00081055

    OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

    Not yet reported Mesoblast International Sàrl 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00084695

    Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

    Not yet reported Milton S. Hershey Medical Center 25 participants 1 site Stand-alone
    Other conditions: Childhood Langerhans Cell Histiocytosis, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00092937

    Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2010-04-06 1 site
    Other conditions: Granulomatous Disease, Chronic
    View official trial listing →
  • Status unknown NCT NCT00093587

    Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

    Not yet reported Jonsson Comprehensive Cancer Center 1 site
    Other conditions: Graft Versus Host Disease, Leukemia
    View official trial listing →
  • Completed NCT NCT00112645

    Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

    Not yet reported Milton S. Hershey Medical Center 10 participants Est. completion 2011-02 1 site
    Other conditions: Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00113919

    UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients

    Not yet reported, Not yet reported University of Arkansas 14 participants Est. completion 2009-10 2 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00134017

    Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00143845

    Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

    Not yet reported University of Michigan Rogel Cancer Center 54 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade
    View official trial listing →
  • Terminated NCT NCT00145587

    Stem Cell Transplantation for Children Affected With Osteopetrosis

    Not yet reported St. Jude Children's Research Hospital 15 participants Est. completion 2009-02 1 site
    Other conditions: Osteopetrosis
    View official trial listing →
  • Completed NCT NCT00152113

    Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound

    Not yet reported St. Jude Children's Research Hospital 5 participants Est. completion 2009-01 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00152126

    Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

    Not yet reported St. Jude Children's Research Hospital 26 participants Est. completion 2009-02 1 site
    Other conditions: Neuroblastoma, Central Nervous System Tumors, Lymphomas, Wilms Tumor
    View official trial listing →
  • Completed NCT NCT00153985

    Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

    Not yet reported Dana-Farber Cancer Institute 2 participants Est. completion 2009-07 6 sites
    Other conditions: Hemoglobinopathies, Sickle Cell Disease, Thalassemia
    View official trial listing →
  • Status unknown NCT NCT00156858

    Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

    Not yet reported Alberta Health services 200 participants Est. completion 2010-12 1 site
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT00167219

    Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 15 participants Est. completion 2023-08-09 1 site Stand-alone
    Other conditions: Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT00176826

    T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome, Griscelli Syndrome, Immunologic Diseases, Langerhans-Cell Histiocytosis, Hematologic Diseases
    View official trial listing →
  • Terminated NCT NCT00176839

    Stem Cell Transplantation for Hematological Malignancies

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 11 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Leukemia, Lymphocytic, Acute, AML, MDS
    View official trial listing →
  • Completed NCT NCT00176852

    Stem Cell Transplant for Hemoglobinopathy

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2020-01 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia, Diamond-Blackfan Anemia, Shwachman-Diamond Syndrome
    View official trial listing →
  • Completed NCT NCT00176878

    Stem Cell Transplant for Bone Marrow Failure Syndromes

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 10 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Diamond-Blackfan Anemia, Kostmann's Neutropenia, Shwachman-Diamond Syndrome
    View official trial listing →
  • Completed NCT NCT00176904

    Stem Cell Transplant for Inborn Errors of Metabolism

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 135 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy, Gaucher's Disease, Fucosidosis, Wolman Disease, Niemann-Pick Disease, Batten Disease, GM1 Gangliosidosis, Tay Sachs Disease, Sandhoff Disease
    View official trial listing →
  • Completed NCT NCT00176917

    Stem Cell Transplantation for Hurler

    Not yet reported Masonic Cancer Center, University of Minnesota 41 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Mannosidosis, Mucolipidosis Type II (I-cell Disease)
    View official trial listing →
  • Terminated NCT NCT00176930

    Stem Cell Transplant for Hematological Malignancy

    Not yet reported Masonic Cancer Center, University of Minnesota 330 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute, MDS, Leukemia, Lymphocytic, Chronic, JMML, Hodgkin's Disease, Non-hodgkin's Lymphoma, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00179764

    Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

    Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 68 participants Est. completion 2014-01-24 1 site
    Other conditions: Tumors, Malignant Melanoma, Hematological Malignancies, Myelogenous Leukemia, Chronic, Leukemia, Lymphoblastic, Acute
    View official trial listing →
  • Completed NCT NCT00179790

    Reduced Intensity Transplant Using Extracorporeal Photopheresis

    Not yet reported, Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 22 participants Est. completion 2015-01 1 site
    Other conditions: Leukemia, Cancer
    View official trial listing →
  • Terminated NCT NCT00185523

    Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

    Stanford University 88 participants Est. completion 2009-04 1 site
    Other conditions: Leukemia, Lymphocytic, Acute, Leukemia, Leukemia Acute Promyelocytic Leukemia (APL), Leukemia Acute Lymphoid Leukemia (ALL), Leukemia Chronic Myelogenous Leukemia (CML), Leukemia Acute Myeloid Leukemia (AML), Leukemia Chronic Lymphocytic Leukemia (CLL)
    View official trial listing →
  • Completed NCT NCT00186342

    Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

    Not yet reported Stanford University 120 participants Est. completion 2009-01 1 site
    Other conditions: Acute Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT), Myelodysplastic Syndromes (MDS), Leukemia
    View official trial listing →
  • Completed NCT NCT00186810

    Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease

    Not yet reported St. Jude Children's Research Hospital 15 participants Est. completion 2007-10 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00186966

    Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

    Not yet reported Dutch Childhood Oncology Group 394 participants Est. completion 2010-09 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00189488

    Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

    Not yet reported Swedish Orphan Biovitrum 155 participants Est. completion 2013-08 Stand-alone
    Other conditions: Graft Versus Host Disease, Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00208923

    Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies

    Not yet reported Emory University 55 participants Est. completion 2007-10 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Withdrawn NCT NCT00226512

    To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

    Not yet reported Hadassah Medical Organization 203 participants 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00228852

    IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency

    Not yet reported, Not yet reported Emory University Est. completion 2006-11 1 site
    Other conditions: T-Cell Immune Deficiency Diseases, Severe Combined Immunodeficiency
    View official trial listing →
  • Completed NCT NCT00238368

    Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59 participants Est. completion 2007-09-17 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00238433

    Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

    Not yet reported OHSU Knight Cancer Institute 37 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00245037

    Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported, Not yet reported OHSU Knight Cancer Institute 147 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition
    View official trial listing →
  • Terminated NCT NCT00245115

    Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7 participants Est. completion 2012-01 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00248547

    Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

    Not yet reported OHSU Knight Cancer Institute 40 participants Est. completion 2009-01 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00253487

    Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas

    Not yet reported Children's Hospital Medical Center, Cincinnati Est. completion 2012-08
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Terminated NCT NCT00253552

    G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

    Not yet reported OHSU Knight Cancer Institute 4 participants Est. completion 2006-05 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Sarcoma
    View official trial listing →
  • Completed NCT NCT00258427

    Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

    Not yet reported Masonic Cancer Center, University of Minnesota 14 participants Est. completion 2020-10-10 1 site Stand-alone
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Completed NCT NCT00265889

    Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

    Not yet reported Case Comprehensive Cancer Center 42 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00275678

    Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies

    Not yet reported Mayo Clinic 15 participants 1 site
    Other conditions: Blood Stem Cell Transplant
    View official trial listing →
  • Terminated NCT NCT00281879

    Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

    Not yet reported OHSU Knight Cancer Institute 200 participants Est. completion 2008-03 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unusual Cancers of Childhood
    View official trial listing →
  • Completed NCT NCT00281983

    Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

    Not yet reported, Not yet reported German CLL Study Group 100 participants Est. completion 2010-07 13 sites Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00282282

    Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 31 participants Est. completion 2009-07 1 site
    Other conditions: Graft Versus Host Disease, GVHD
    View official trial listing →
  • Terminated NCT NCT00290628

    Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 43 participants Est. completion 2007-04 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Diamond-blackfan Anemia, Fanconi Anemia, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Status unknown NCT NCT00295997

    Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

    Not yet reported University of California, San Francisco 35 participants 2 sites
    Other conditions: Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00296023

    Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

    Not yet reported University of California, San Francisco 25 participants Est. completion 2008-06 2 sites Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00301834

    Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

    Not yet reported University of California, San Francisco 35 participants Est. completion 2011-09 2 sites Stand-alone
    Other conditions: Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Leukemia, Myelodysplastic Syndromes, Severe Congenital Neutropenia
    View official trial listing →
  • Withdrawn NCT NCT00301912

    Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Not yet reported University of California, San Francisco 1 site
    Other conditions: Anemia, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00301951

    Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

    Not yet reported University of California, San Francisco 7 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00304018

    Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

    Not yet reported University of California, San Francisco 5 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00305708

    Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

    Not yet reported, Not yet reported University of California, San Francisco 40 participants Est. completion 2004-07 1 site
    Other conditions: Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Fanconi Anemia, Leukemia, Severe Congenital Neutropenia, Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00313625

    Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center 20 participants 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Status unknown NCT NCT00317408

    Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

    Not yet reported European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma 96 participants 98 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00322101

    Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

    Not yet reported Fred Hutchinson Cancer Center 25 participants Est. completion 2014-10 8 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00328029

    Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population

    Not yet reported University Hospital, Strasbourg, France 35 participants Est. completion 2012-06 2 sites
    Other conditions: Signs and Symptoms, Respiratory
    View official trial listing →
  • Completed NCT NCT00333190

    CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2009-03 2 sites
    Other conditions: Hematologic Malignancy, AML, ALL, CML, Multiple Myeloma, NHL, Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00334360

    Dexmed/Buspirone Synergism on Shivering

    Not yet reported The Cleveland Clinic 8 participants Est. completion 2007-08 1 site
    Other conditions: Hypothermia
    View official trial listing →
  • Status unknown NCT NCT00334672

    Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis

    Not yet reported Children's Cancer and Leukaemia Group 288 participants 13 sites
    Other conditions: Nonneoplastic Condition
    View official trial listing →
  • Completed NCT NCT00336843

    Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma

    Not yet reported Asan Medical Center 19 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00342316

    Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

    Not yet reported Vastra Gotaland Region 340 participants Est. completion 2018-07-20 25 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00346359

    Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2007-11 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00350181

    Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

    Not yet reported Stanford University 11 participants Est. completion 2010-04 1 site
    Other conditions: Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases, Acute GVHD
    View official trial listing →
  • Completed NCT NCT00357396

    Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 10 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00357565

    Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 34 participants Est. completion 2025-03-11 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes, Childhood Acute Myeloid Leukemia in Remission, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Previously Treated Myelodysplastic Syndrome, Secondary Myelodysplastic Syndrome, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Excess Blasts, Refractory Anemia, De Novo Myelodysplastic Syndrome, Childhood Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00361140

    Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 72 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Myeloma, Lymphoma
    View official trial listing →
  • Terminated NCT NCT00363467

    Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 3 participants Est. completion 2009-05 1 site
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Terminated NCT NCT00394316

    Gene Therapy for Chronic Granulomatous Disease

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 3 participants Est. completion 2014-04-08 1 site
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Withdrawn NCT NCT00396968

    AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS

    Not yet reported, Not yet reported Genzyme, a Sanofi Company
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00402558

    Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Status unknown NCT NCT00408447

    Stem Cell Transplant in Sickle Cell Disease and Thalassemia

    Not yet reported Columbia University 53 participants Est. completion 2025-02 1 site
    Other conditions: Sickle Cell Disease, Beta Thalassemia
    View official trial listing →
  • Completed NCT NCT00410982

    Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies

    Not yet reported M.D. Anderson Cancer Center 145 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myeloma
    View official trial listing →
  • Completed NCT NCT00416598

    Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 546 participants Est. completion 2016-12-01 46 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Untreated Adult Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT00417053

    Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant

    Not yet reported Children's Cancer and Leukaemia Group
    Other conditions: Neuroblastoma
    View official trial listing →
  • No Longer Available NCT NCT00423826

    Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

    Barbara Ann Karmanos Cancer Institute Est. completion 2015-01 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00426517

    Donor Stem Cell Transplantation for Congenital Immunodeficiencies

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2019-11-01 1 site Stand-alone
    Other conditions: Inherited Immune Deficiencies
    View official trial listing →
  • Completed NCT NCT00427661

    A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

    Not yet reported University of Pittsburgh 8 participants Est. completion 2014-05 1 site
    Other conditions: Sickle Cell Disease, Thalassemia, Hemoglobinopathies
    View official trial listing →
  • Completed NCT NCT00427765

    Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

    Not yet reported M.D. Anderson Cancer Center 168 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Multiple Myeloma, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00436761

    Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

    Not yet reported Milton S. Hershey Medical Center 20 participants 1 site
    Other conditions: Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00445744

    Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center 52 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Myelodysplastic Syndrome With Isolated Del(5q), Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    View official trial listing →
  • Withdrawn NCT NCT00446173

    Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia

    Not yet reported M.D. Anderson Cancer Center Est. completion 2009-01 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00448201

    Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 71 participants Est. completion 2012-05-23 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00448357

    Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

    Not yet reported, Not yet reported UNC Lineberger Comprehensive Cancer Center 54 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00454480

    Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    Not yet reported, Not yet reported The University of New South Wales 2000 participants 96 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00458250

    Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H

    Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2008-02 1 site
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute
    View official trial listing →
  • Completed NCT NCT00469014

    Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

    Not yet reported M.D. Anderson Cancer Center 72 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00469144

    IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 233 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Leukemia, Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00475020

    Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 63 participants Est. completion 2017-10-04 1 site Stand-alone
    Other conditions: Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00477542

    A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT

    Not yet reported Indiana University 18 participants Est. completion 2010-11 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Terminated NCT NCT00478244

    Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa

    Not yet reported Masonic Cancer Center, University of Minnesota 7 participants Est. completion 2011-08 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00496340

    Phase II Trial of Pentostatin and Targeted Busulfan

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 42 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00498316

    Cord Blood Expansion on Mesenchymal Stem Cells

    Not yet reported M.D. Anderson Cancer Center 98 participants Est. completion 2016-10 1 site
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Terminated NCT NCT00499889

    Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

    Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00502905

    Busulfan and Fludarabine in Patients With AML and MDS

    Not yet reported M.D. Anderson Cancer Center 200 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00506857

    Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 82 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00513474

    Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

    Not yet reported Massachusetts General Hospital 46 participants Est. completion 2013-02-12 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00516152

    Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT

    Not yet reported University of California, San Francisco 36 participants Est. completion 2007-11 1 site
    Other conditions: Chronic Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplasia, Acute Lymphocytic Leukemia, Severe Aplastic Anemia, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease, Multiple Myeloma, Advanced Myeloproliferative Disease
    View official trial listing →
  • Completed NCT NCT00521430

    Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

    Not yet reported Asan Medical Center 30 participants Est. completion 2008-09 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Nonmalignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00531310

    Reduced Intensity AlloSCT in(CML) With Persistent Disease

    Not yet reported Columbia University 5 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Chronic Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00534430

    Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

    Not yet reported City of Hope Medical Center 30 participants Est. completion 2026-02-02 Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00534469

    Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

    Not yet reported City of Hope Medical Center 60 participants Est. completion 2025-07-16 Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00536601

    High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

    Not yet reported Roswell Park Cancer Institute 174 participants Est. completion 2018-07-09 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET), Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Plasma Cell Neoplasm, Primary Systemic Amyloidosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Neuroblastoma, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Regional Neuroblastoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    View official trial listing →
  • Terminated NCT NCT00540995

    Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

    Not yet reported, Not yet reported City of Hope Medical Center 25 participants Est. completion 2011-08-09 1 site Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts
    View official trial listing →
  • Active, not recruiting NCT NCT00544115

    Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

    Not yet reported City of Hope Medical Center 260 participants Est. completion 2027-03-29
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant Condition
    View official trial listing →
  • Completed NCT NCT00547196

    AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2024-05-28 2 sites Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes
    View official trial listing →
  • Withdrawn NCT NCT00549835

    Acupuncture for Mucositis Pain in Cancer Care

    Not yet reported Johns Hopkins University Est. completion 2009-10 1 site
    Other conditions: Mucositis, Pain, Leukemia
    View official trial listing →
  • Status unknown NCT NCT00550992

    Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia

    Not yet reported Dutch Childhood Oncology Group 445 participants 13 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00553202

    Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

    Not yet reported Children's Oncology Group 158 participants Est. completion 2020-03-31 52 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00555048

    Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 1 participants 2 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00556452

    Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 46 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT00578292

    Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

    Not yet reported Baylor College of Medicine 10 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Thalassemia
    View official trial listing →
  • Terminated NCT NCT00578344

    Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP

    Not yet reported Tami D. John 8 participants Est. completion 2012-07 2 sites Stand-alone
    Other conditions: Sickle Cell Disease, Hemoglobin SC
    View official trial listing →
  • Completed NCT NCT00578435

    Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis

    Not yet reported Memorial Sloan Kettering Cancer Center 25 participants Est. completion 2008-08 1 site
    Other conditions: Genetic Disorders, Sickle Cell Anemia
    View official trial listing →
  • Completed NCT NCT00578643

    Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease

    Not yet reported Baylor College of Medicine 15 participants Est. completion 2017-11-24 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Terminated NCT NCT00579111

    Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

    Not yet reported, Not yet reported Baylor College of Medicine 4 participants Est. completion 2010-10 2 sites Stand-alone
    Other conditions: Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoproliferative Disorders, Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT00582894

    Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

    Not yet reported University of Oklahoma 17 participants Est. completion 2008-03 1 site
    Other conditions: Hematological Neoplasms, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00582933

    Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

    Not yet reported Memorial Sloan Kettering Cancer Center 96 participants Est. completion 2009-04 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Allogeneic Marrow Transplant
    View official trial listing →
  • Completed NCT NCT00588523

    Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

    Not yet reported Memorial Sloan Kettering Cancer Center 60 participants Est. completion 2023-02-02 3 sites Stand-alone
    Other conditions: CNS Cancer, CNS BRAIN
    View official trial listing →
  • Completed NCT NCT00596154

    Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center 33 participants Est. completion 2023-02-02 3 sites Stand-alone
    Other conditions: CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00597714

    Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant

    Not yet reported David Rizzieri, MD 264 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Hodgkin's Disease, Non Hodgkin's Lymphoma, Myeloma, Leukemia, Myelodysplasia
    View official trial listing →
  • Completed NCT NCT00598481

    ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID

    Not yet reported Fondazione Telethon 12 participants Est. completion 2019-06-19 2 sites Stand-alone
    Other conditions: Immunologic Deficiency Syndromes
    View official trial listing →
  • Completed NCT NCT00611351

    Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

    Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00612716

    Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 6 participants Est. completion 2019-12-15 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Status unknown NCT NCT00613561

    Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases

    Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 25 participants Est. completion 2017-12 1 site
    Other conditions: Severe Immunodeficiency Diseases
    View official trial listing →
  • Terminated NCT NCT00615589

    Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen

    Not yet reported University of Michigan Rogel Cancer Center 22 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Multiple Myeloma, Plasma Cell Leukemia
    View official trial listing →
  • Completed NCT NCT00618969

    Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

    Not yet reported University of Arizona 2 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Hematologic Neoplasms, Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00619645

    Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

    Not yet reported University of California, Davis 8 participants Est. completion 2013-11 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00619879

    Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

    Ann & Robert H Lurie Children's Hospital of Chicago 81 participants Est. completion 2019-02-07 1 site
    Other conditions: Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute, Myeloproliferative-Myelodysplastic Diseases, Lymphoma, Malignant
    View official trial listing →
  • Terminated NCT NCT00623077

    MT2004-30: Tomotherapy for Solid Tumors

    Not yet reported Masonic Cancer Center, University of Minnesota 23 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Kidney Cancer, Liver Cancer, Retinoblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00623935

    Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia

    Not yet reported University of Michigan Rogel Cancer Center 56 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT00627666

    Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

    Not yet reported Asan Medical Center 52 participants Est. completion 2010-06 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00629798

    Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

    Not yet reported Memorial Sloan Kettering Cancer Center 64 participants Est. completion 2020-10-20 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Advanced Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00630565

    Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 12 participants Est. completion 2022-07-28 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00638820

    Reduced Intensity AlloTransplant For Osteopetrosis

    Not yet reported Masonic Cancer Center, University of Minnesota 3 participants Est. completion 2008-05 1 site Stand-alone
    Other conditions: Osteopetrosis
    View official trial listing →
  • Completed NCT NCT00638898

    Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

    Not yet reported City of Hope Medical Center 25 participants Est. completion 2024-12-10 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Solid Tumor, Adult Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Soft Tissue Sarcoma, Ewing Sarcoma, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Ovarian Mixed Germ Cell Tumor, Recurrent Adult Brain Tumor, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Medulloblastoma, Recurrent Childhood Pineoblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Extragonadal Germ Cell Tumor, Recurrent Extragonadal Non-seminomatous Germ Cell Tumor, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Neuroblastoma, Recurrent Ovarian Germ Cell Tumor, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00667927

    Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission

    Not yet reported St. Jude Children's Research Hospital 17 participants Est. completion 2008-01 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT00668564

    Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism

    Not yet reported Masonic Cancer Center, University of Minnesota 18 participants Est. completion 2010-02 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Hurler's Syndrome, Maroteaux-Lamy Syndrome, Sly Syndrome, Alpha Mannosidosis, Fucosidosis, Sphingolipidoses, Krabbe Disease, Wolman's Disease, Niemann-Pick Disease Type B, Niemann-Pick Disease, Type C
    View official trial listing →
  • Terminated NCT NCT00669890

    Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML

    Not yet reported New York Medical College 12 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT00670410

    Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma

    Not yet reported Columbia University 15 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00676806

    A Phase II Study of Umbilical Cord Blood Transplantation

    Not yet reported Tufts Medical Center 7 participants Est. completion 2014-07 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma, Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT00679536

    Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors

    Not yet reported, Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 30 participants Est. completion 2015-05 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00684255

    Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)

    Not yet reported New York Medical College 1 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus, Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT00691015

    Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

    Not yet reported Barbara Ann Karmanos Cancer Institute 48 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00705120

    Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation

    Not yet reported St. Jude Children's Research Hospital 9 participants Est. completion 2007-10 1 site
    Other conditions: Osteogenesis Imperfecta
    View official trial listing →
  • Completed NCT NCT00731328

    Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

    Not yet reported Asan Medical Center 15 participants Est. completion 2013-12 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Nonmalignant Neoplasm, Paroxysmal Nocturnal Hemoglobinuria
    View official trial listing →
  • Completed NCT NCT00732316

    Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

    Not yet reported Asan Medical Center 54 participants Est. completion 2011-05 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00740467

    Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

    Not yet reported Institut Paoli-Calmettes 50 participants 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    View official trial listing →
  • Status unknown NCT NCT00750126

    Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported University Hospital, Clermont-Ferrand 30 participants Est. completion 2009-04 1 site
    Other conditions: Solid Tumors, Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT00763490

    Trial Of Double Umbilical Cord Blood Transplantation

    Not yet reported University of Michigan Rogel Cancer Center 20 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT00774280

    Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen

    Not yet reported Cooperative Study Group A for Hematology 130 participants Est. completion 2010-12 1 site
    Other conditions: Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00775931

    Allogeneic Transplantation For Severe Osteopetrosis

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 7 participants Est. completion 2013-06 1 site
    Other conditions: Severe Osteopetrosis
    View official trial listing →
  • Completed NCT NCT00782379

    Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer

    Not yet reported Northside Hospital, Inc. 20 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00785330

    Allo-hNHL (FluBuCy)

    Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 84 participants Est. completion 2011-04 6 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00787761

    Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

    Not yet reported Northside Hospital, Inc. 24 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00794508

    MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID

    Not yet reported Donald B. Kohn, M.D. 10 participants Est. completion 2015-01 1 site
    Other conditions: Severe Combined Immunodeficiency
    View official trial listing →
  • Completed NCT NCT00795132

    Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

    Not yet reported University of Utah 47 participants Est. completion 2009-07 1 site
    Other conditions: Acute Leukaemia, Chronic Disease, Leukemia, Myelodysplasia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00796562

    Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 107 participants Est. completion 2016-11 2 sites Stand-alone
    Other conditions: MDS, Leukemias, Lymphomas
    View official trial listing →
  • Completed NCT NCT00800839

    Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

    Not yet reported M.D. Anderson Cancer Center 56 participants 1 site Stand-alone
    Other conditions: Hematologic Diseases, Leukemia, Lymphoma, Myeloma
    View official trial listing →
  • Terminated NCT NCT00801931

    Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

    Not yet reported, Not yet reported Columbia University 1 participants Est. completion 2009-05-05 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Neuroblastoma, Immunodeficiencies, Anemia
    View official trial listing →
  • Completed NCT NCT00802113

    Autologous and Allogeneic Transplant for Relapsed Lymphoma

    Not yet reported, Not yet reported Columbia University 30 participants Est. completion 2014-10-22 6 sites Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma, Hodgkins Disease
    View official trial listing →
  • Completed NCT NCT00802568

    Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

    Not yet reported Institut Paoli-Calmettes 48 participants 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Status unknown NCT NCT00804947

    Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen

    Not yet reported Fundacion Para La Investigacion Hospital La Fe 50 participants Est. completion 2010-03 6 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00806767

    Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

    Not yet reported Institut Paoli-Calmettes 82 participants 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00809276

    Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92 participants Est. completion 2011-12 3 sites
    Other conditions: Lymphoma, Multiple Myeloma, Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00810602

    Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

    Not yet reported, Not yet reported Pavan Reddy, MD 61 participants Est. completion 2013-07 2 sites Stand-alone
    Other conditions: Hematologic Malignancies, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT00813124

    Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

    Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia
    View official trial listing →
  • Status unknown NCT NCT00815568

    Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)

    Not yet reported Samsung Medical Center 114 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: AML, MDS, ALL, CML, Lymphoma
    View official trial listing →
  • Terminated NCT NCT00818961

    Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

    Not yet reported Northside Hospital, Inc. 36 participants Est. completion 2012-03 1 site
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00822393

    Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

    Not yet reported medac GmbH 570 participants Est. completion 2018-01-25 33 sites
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00822770

    Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 47 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia
    View official trial listing →
  • Withdrawn NCT NCT00836628

    Study of Busulfan for Refractory Central Nervous System (CNS) Tumors

    Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago Est. completion 2010-10 Stand-alone
    Other conditions: Refractory Brain Tumors
    View official trial listing →
  • Completed NCT NCT00840684

    Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

    Not yet reported, Not yet reported Institut Paoli-Calmettes 135 participants 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00841724

    Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

    Not yet reported Nantes University Hospital 82 participants Est. completion 2012-01 3 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT00843947

    Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan

    Not yet reported University of California, Davis 8 participants Est. completion 2013-11 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00852163

    Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

    Not yet reported Baylor Research Institute 20 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00857389

    Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

    Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-03-09 1 site Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00863148

    Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Nantes University Hospital 30 participants Est. completion 2013-06 6 sites
    Other conditions: MDS, AML, ALL, BAL
    View official trial listing →
  • Status unknown NCT NCT00863460

    Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

    Not yet reported Institut Curie 140 participants Est. completion 2026-05 23 sites
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00874315

    Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

    Not yet reported Nationwide Children's Hospital Est. completion 2012-06 4 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00881556

    Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

    Not yet reported Columbia University 3 participants Est. completion 2015-09 3 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00885833

    Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)

    Not yet reported, Not yet reported The Korean Society of Pediatric Hematology Oncology 5 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Wiskott-Aldrich Syndrome
    View official trial listing →
  • Completed NCT NCT00886522

    Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 23 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Status unknown NCT NCT00887042

    Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

    Not yet reported, Not yet reported The Korean Society of Pediatric Hematology Oncology 35 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00894049

    A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation

    Not yet reported Institut Paoli-Calmettes 148 participants Est. completion 2013-02 5 sites Stand-alone
    Other conditions: Allograft, Allogeneic Cell Transplantaion, Hematological Malignancy, Solid Tumor
    View official trial listing →
  • Terminated NCT NCT00907582

    ASCT for Relapsed APL After Molecular Remission

    Not yet reported Shanghai Jiao Tong University School of Medicine 5 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Acute Promyelocytic Leukemia, Relapse
    View official trial listing →
  • Completed NCT NCT00914849

    Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

    Not yet reported Washington University School of Medicine 68 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Terminated NCT NCT00915811

    Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin

    Not yet reported King's College Hospital NHS Trust 20 participants Est. completion 2011-06 1 site
    Other conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute
    View official trial listing →
  • Terminated NCT NCT00916045

    Pilot Study of Unrelated Cord Blood Transplantation

    Not yet reported King's College Hospital NHS Trust 40 participants Est. completion 2012-03 1 site
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Leukemia, Lymphoblastic, Acute, Lymphoma, Non-Hodgkin, Hodgkin Disease, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT00934232

    Busulfan in Multiple Myeloma

    Not yet reported Guido Tricot 13 participants Est. completion 2012-02 Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00941720

    Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

    Not yet reported Case Comprehensive Cancer Center 71 participants Est. completion 2013-02-28 1 site Stand-alone
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00943319

    Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies

    Not yet reported, Not yet reported University of Chicago 50 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myeloma
    View official trial listing →
  • Completed NCT NCT00943800

    Combined Haploidentical-Cord Blood Transplantation for Adults and Children

    Not yet reported University of Chicago 87 participants Est. completion 2018-09 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, Lymphoma
    View official trial listing →
  • Completed NCT NCT00948090

    PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 207 participants Est. completion 2013-06 42 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00950846

    Umbilical Cord Blood Transplant for Congenital Pediatric Disorders

    Not yet reported Baylor College of Medicine 40 participants Est. completion 2021-02-04 1 site Stand-alone
    Other conditions: Congenital Pediatric Disorders
    View official trial listing →
  • Terminated NCT NCT00966498

    Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

    Not yet reported Emory University 3 participants Est. completion 2011-07 2 sites Stand-alone
    Other conditions: High Risk Solid Tumors, Recurrent Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT00966810

    Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion

    Not yet reported, Not yet reported Rambam Health Care Campus 40 participants Est. completion 2011-01 1 site Stand-alone
    Other conditions: Philadelphia Chromosome-positive Chronic Myelocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00968162

    Sickle Cell Disease Conditioning for Bone Marrow Transplant

    Not yet reported Emory University 8 participants Est. completion 2016-01-11 10 sites Stand-alone
    Other conditions: Bone Marrow Transplantation, Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00984230

    A New Adaptive Feeding Plan for Newborns

    Not yet reported Société des Produits Nestlé (SPN) 186 participants Est. completion 2011-02 6 sites
    Other conditions: Infant Nutrition
    View official trial listing →
  • Completed NCT NCT00987480

    Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine

    Not yet reported Memorial Sloan Kettering Cancer Center 45 participants Est. completion 2017-07-10 6 sites Stand-alone
    Other conditions: Aplastic Anemia, Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00987636

    Study in Localized and Disseminated Ewing Sarcoma

    Not yet reported University Hospital Muenster 907 participants Est. completion 2019-03-31 2 sites Stand-alone
    Other conditions: Ewing's Sarcoma
    View official trial listing →
  • Completed NCT NCT00988013

    Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies

    Not yet reported University of Illinois at Chicago 14 participants Est. completion 2016-02 1 site
    Other conditions: Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia, Non Hodgkins Lymphoma, Chronic Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00990249

    Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 120 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00997386

    Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States

    Not yet reported University of Arizona 16 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Hematologic Neoplasms, Multiple Myeloma, Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Myelofibrosis
    View official trial listing →
  • Completed NCT NCT01003054

    Autologous Transplantation for Chronic Myelogenous Leukemia

    Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Chronic Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01009840

    IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 30 participants Est. completion 2012-03-01 13 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01015742

    Unrelated Double Umbilical Cord Blood Units Transplantation

    Not yet reported, Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myeloid, Chronic
    View official trial listing →
  • Completed NCT NCT01018446

    Hematopoietic Stem Cell Transplantation Based on Pharmacokinetic and Pharmacodynamic Modeling

    Not yet reported Seoul National University Hospital 30 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT01019876

    Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

    Not yet reported, Not yet reported Columbia University 38 participants Est. completion 2021-09-07 1 site
    Other conditions: Bone Marrow Failure, Osteopetrosis, Fanconi Anemia, Severe Combined Immunodeficiency
    View official trial listing →
  • Completed NCT NCT01020539

    Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

    Not yet reported Columbia University 18 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01020734

    Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

    Not yet reported Asan Medical Center 263 participants Est. completion 2015-07 2 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT01027000

    Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 68 participants Est. completion 2023-04 25 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01033552

    Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 32 participants Est. completion 2021-08-12 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT01037764

    Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Asan Medical Center 100 participants Est. completion 2016-12 2 sites Stand-alone
    Other conditions: Acute Lymphoid Leukemia
    View official trial listing →
  • Completed NCT NCT01043640

    Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders

    Not yet reported Masonic Cancer Center, University of Minnesota 46 participants Est. completion 2017-06 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Mucopolysaccharidosis, Hurler Syndrome, Hunter Syndrome, Maroteaux-Lamy Syndrome, Sly Syndrome, Alpha Mannosidosis, Fucosidosis, Adrenoleukodystrophy (ALD), Krabbe Disease, Metachromatic Leukodystrophy (MLD), Sphingolipidoses, Peroxisomal Disorders
    View official trial listing →
  • Terminated NCT NCT01044745

    Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported University of Nebraska 20 participants Est. completion 2017-10-10 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Graft Versus Host Disease, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01048827

    Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen

    Not yet reported University of California, San Francisco 12 participants Est. completion 2015-02-25 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01049854

    CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

    Not yet reported New York Medical College 20 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Bone Marrow Failure, Immunodeficiencies, Histiocytosis, Sickle Cell Disease, Beta Thalassemia, Inborn Errors of Metabolism
    View official trial listing →
  • Completed NCT NCT01050036

    Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia

    Not yet reported Asan Medical Center 20 participants Est. completion 2018-10-30 11 sites Stand-alone
    Other conditions: Leukemia, Myeloid
    View official trial listing →
  • Terminated NCT NCT01050439

    Unrelated Donor Transplant for Malignant and Non-Malignant Disorders

    Not yet reported Columbia University 22 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Bone Marrow Failure Syndromes, Immunodeficiencies, Histiocytosis
    View official trial listing →
  • Terminated NCT NCT01050946

    Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit

    Not yet reported Medical College of Wisconsin 1 participants Est. completion 2013-03
    Other conditions: Leukemia, Lymphocytic, Acute, Leukemia, Lymphocytic, Chronic, Leukemia, Myelocytic, Acute, Leukemia, Myeloid, Chronic, Lymphoma, Non-Hodgkin, Lymphoma, Hodgkins
    View official trial listing →
  • Completed NCT NCT01056614

    Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies

    Not yet reported Fred Hutchinson Cancer Center 23 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Hematopoietic/Lymphoid Cancer, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia
    View official trial listing →
  • Status unknown NCT NCT01063439

    BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)

    Not yet reported Inje University 42 participants Est. completion 2015-02 5 sites Stand-alone
    Other conditions: Non Hodgkin's Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01067300

    A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission

    Not yet reported Assistance Publique Hopitaux De Marseille 198 participants Est. completion 2016-01 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT01071239

    Hematopoietic Stem Cell Transplant for Fanconi Anemia

    Not yet reported Medical College of Wisconsin 1 participants Est. completion 2016-08-30 1 site Stand-alone
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Withdrawn NCT NCT01071486

    Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation

    Not yet reported Rambam Health Care Campus Est. completion 2012-10 1 site
    Other conditions: Busulfan Pharmacokinetic Analysis, GST Genetic Polymorphism
    View official trial listing →
  • Status unknown NCT NCT01087398

    Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis

    Not yet reported, Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Osteopetrosis
    View official trial listing →
  • Completed NCT NCT01093586

    Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Case Comprehensive Cancer Center 14 participants Est. completion 2015-12 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Erythroleukemia (M6a), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Pure Erythroid Leukemia (M6b), B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Burkitt Lymphoma, Childhood Acute Erythroleukemia (M6), Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Previously Treated Myelodysplastic Syndromes, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Splenic Marginal Zone Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01099930

    Autologous Stem Cell Transplant for Multiple Sclerosis

    Not yet reported Ottawa Hospital Research Institute 24 participants Est. completion 2016-06 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT01118013

    Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

    Not yet reported Alliance for Clinical Trials in Oncology 6 participants Est. completion 2013-08 10 sites Stand-alone
    Other conditions: Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT01119066

    HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    Not yet reported Memorial Sloan Kettering Cancer Center 422 participants Est. completion 2021-03-30 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01129544

    Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

    Not yet reported, Not yet reported David Williams 8 participants Est. completion 2023-03 3 sites Stand-alone
    Other conditions: Severe Combined Immunodeficiency
    View official trial listing →
  • Completed NCT NCT01131169

    Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

    Not yet reported Memorial Sloan Kettering Cancer Center 66 participants Est. completion 2020-05-15 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT01135329

    Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Lymphoma, Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01141543

    Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection

    University Health Network, Toronto 12 participants Est. completion 2014-05 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT01156350

    Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma

    Not yet reported University Hospital, Clermont-Ferrand 10 participants Est. completion 2014-09 1 site
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01158118

    Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

    Not yet reported Washington University School of Medicine 48 participants Est. completion 2016-12-31 1 site
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Lymphoma, Non-Hodgkin, Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01168219

    Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 68 participants Est. completion 2020-02-01 17 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With Maturation, Adult Acute Myeloid Leukemia With Minimal Differentiation, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Adult Acute Myeloid Leukemia Without Maturation, Adult Acute Myelomonocytic Leukemia, Adult Erythroleukemia, Adult Pure Erythroid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01175356

    Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

    Not yet reported Children's Oncology Group 99 participants Est. completion 2025-12-31 25 sites Stand-alone
    Other conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Active, not recruiting NCT NCT01176006

    Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

    Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2028-10-31 1 site
    Other conditions: DOCK8 Deficiency
    View official trial listing →
  • Completed NCT NCT01177371

    High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

    Not yet reported Case Comprehensive Cancer Center 13 participants Est. completion 2010-02 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With T(15;17)(q22;q12), Adult Acute Myeloid Leukemia With T(16;16)(p13;q22), Adult Acute Myeloid Leukemia With T(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Acute Promyelocytic Leukemia (M3), Adult Erythroleukemia (M6a), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Pure Erythroid Leukemia (M6b), Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Burkitt Lymphoma, Childhood Acute Erythroleukemia (M6), Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myeloid Leukemia in Remission, Childhood Acute Myelomonocytic Leukemia (M4), Childhood Acute Promyelocytic Leukemia (M3), Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, De Novo Myelodysplastic Syndromes, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-Cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Status unknown NCT NCT01178645

    Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma

    Not yet reported Seoul National University Hospital 42 participants 5 sites Stand-alone
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01178658

    Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

    Not yet reported Seoul National University Hospital 42 participants 5 sites Stand-alone
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01181271

    Tandem Auto-Allo Transplant for Lymphoma

    Not yet reported Massachusetts General Hospital 42 participants Est. completion 2016-02 2 sites Stand-alone
    Other conditions: Diffuse, Large B-Cell, Lymphoma, Lymphoma, Low-Grade, T-Cell Lymphoma, Mantle-Cell Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
    View official trial listing →
  • Completed NCT NCT01182415

    High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2016-12 2 sites Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma, CNS Lymphoma
    View official trial listing →
  • Completed NCT NCT01188174

    Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure

    Not yet reported Nantes University Hospital 26 participants Est. completion 2014-12 9 sites Stand-alone
    Other conditions: AML
    View official trial listing →
  • Completed NCT NCT01191957

    Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML

    Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 252 participants Est. completion 2014-10 26 sites
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Completed NCT NCT01200329

    High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

    Not yet reported M.D. Anderson Cancer Center 81 participants Est. completion 2018-12-06 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT01203020

    Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation

    Not yet reported West Virginia University 22 participants Est. completion 2021-09-27 1 site Stand-alone
    Other conditions: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Terminated NCT NCT01203228

    Dose-reduced Versus Standard Conditioning in MDS/sAML

    Not yet reported European Society for Blood and Marrow Transplantation 129 participants Est. completion 2015-02 14 sites Stand-alone
    Other conditions: Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01237951

    High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma

    Not yet reported M.D. Anderson Cancer Center 75 participants Est. completion 2017-09-20 1 site Stand-alone
    Other conditions: Myeloma
    View official trial listing →
  • Status unknown NCT NCT01238328

    Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis

    Not yet reported, Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Mucopolysaccharidosis
    View official trial listing →
  • Completed NCT NCT01244906

    Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

    Not yet reported Northside Hospital, Inc. 26 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT01247701

    Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies

    Not yet reported Baylor College of Medicine 16 participants Est. completion 2019-10 1 site Stand-alone
    Other conditions: Myeloid Hematological Malignancies
    View official trial listing →
  • Status unknown NCT NCT01255527

    Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study

    Not yet reported, Not yet reported Yonsei University 53 participants Est. completion 2014-12 8 sites
    Other conditions: Multiple Myeloma Patients Who Candidate for Autologous Peripheral Blood Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT01257854

    Polymorphisms and Busulfan Pharmacokinetic Study

    University Hospital, Geneva 200 participants Est. completion 2023-12 4 sites
    Other conditions: Children Who Receive a Stem Cell Transplantation With Busulfan IV
    View official trial listing →
  • Status unknown NCT NCT01274195

    Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML

    Not yet reported Seoul National University Hospital 27 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Terminated NCT NCT01279616

    A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

    Not yet reported Nationwide Children's Hospital 8 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT01338675

    Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD)

    Not yet reported, Not yet reported Seoul National University Hospital 5 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Completed NCT NCT01338987

    Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    Not yet reported National Cancer Institute (NCI) 76 participants Est. completion 2020-11-19 3 sites Stand-alone
    Other conditions: Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT01339910

    Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

    Not yet reported Medical College of Wisconsin 272 participants Est. completion 2017-10-16 32 sites Stand-alone
    Other conditions: Leukemia, Myelocytic, Acute
    View official trial listing →
  • Status unknown NCT NCT01339988

    Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

    Not yet reported Tel-Aviv Sourasky Medical Center 10 participants Est. completion 2019-06 Stand-alone
    Other conditions: Acute Leukemias, Chronic Leukemias, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01349101

    A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78 participants Est. completion 2022-12-07 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Terminated NCT NCT01359254

    Cord Blood Transplantation for Patients With Cancer

    Not yet reported University of Chicago 1 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Hematological Disease
    View official trial listing →
  • Completed NCT NCT01364363

    Unrelated Donor Stem Cell Transplantation

    Not yet reported Scripps Health 64 participants Est. completion 2015-07 1 site
    Other conditions: Severe Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Syndromes, Chronic Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Large Granulocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT01366612

    Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation

    Not yet reported Hackensack Meridian Health 53 participants Est. completion 2020-08-18 1 site Stand-alone
    Other conditions: Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia, Myeloproliferative Disorders, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01370408

    Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients

    Not yet reported Northside Hospital, Inc. 85 participants Est. completion 2016-03 1 site
    Other conditions: Chemotherapy-induced Nausea and Vomiting
    View official trial listing →
  • Completed NCT NCT01380990

    Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency

    Not yet reported, Not yet reported Great Ormond Street Hospital for Children NHS Foundation Trust 36 participants Est. completion 2019-12-23 1 site Stand-alone
    Other conditions: Adenosine Deaminase Deficiency, Severe Combined Immunodeficiencies (SCID)
    View official trial listing →
  • Completed NCT NCT01384513

    A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40 participants Est. completion 2022-11-16 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Aplastic Anemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Essential Thrombocythemia, Juvenile Myelomonocytic Leukemia, Mastocytosis, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Anemia, Refractory Anemia With Ringed Sideroblasts, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01390402

    Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Leukemia, Chronic Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01410344

    Allogeneic Transplant in HIV Patients (BMT CTN 0903)

    Not yet reported Medical College of Wisconsin 20 participants Est. completion 2018-06 11 sites
    Other conditions: Leukemia, Lymphoma, HIV
    View official trial listing →
  • Completed NCT NCT01413178

    A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

    Not yet reported M.D. Anderson Cancer Center 205 participants Est. completion 2019-03-10 1 site Stand-alone
    Other conditions: Myeloma
    View official trial listing →
  • Completed NCT NCT01421173

    Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

    Not yet reported M.D. Anderson Cancer Center 78 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT01422603

    Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)

    Not yet reported, Not yet reported University Hospital Southampton NHS Foundation Trust 9 participants Est. completion 2015-03-31 1 site
    Other conditions: Acute Myeloid Leukaemia, Myelodysplasia
    View official trial listing →
  • Completed NCT NCT01427881

    Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

    Not yet reported Fred Hutchinson Cancer Center 43 participants Est. completion 2015-07 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Myeloid Leukemia in Remission, Adult Erythroleukemia (M6a), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Pure Erythroid Leukemia (M6b), Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Philadelphia Chromosome Negative Chronic Myelogenous Leukemia, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Multiple Myeloma, Testicular Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01435447

    Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies

    Not yet reported Shanghai Jiao Tong University School of Medicine 31 participants Est. completion 2018-10-01 1 site Stand-alone
    Other conditions: Lymphoid Malignancies
    View official trial listing →
  • Completed NCT NCT01455506

    PRO#0118: Decitabine Plus Mini Flu-Bu

    Not yet reported Hackensack Meridian Health 20 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01457885

    Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

    Not yet reported University of Michigan Rogel Cancer Center 75 participants Est. completion 2016-06-14 12 sites Stand-alone
    Other conditions: Acute Myeloblastic Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT01461837

    Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

    Not yet reported New York Medical College 21 participants Est. completion 2026-12 6 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Terminated NCT NCT01464359

    T-Cell Depleted Double UCB for Refractory AML

    Not yet reported Masonic Cancer Center, University of Minnesota 3 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Refractory Acute Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01471067

    Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2017-04-25 1 site Stand-alone
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Transplantation, Bone Marrow
    View official trial listing →
  • Completed NCT NCT01471444

    Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    Not yet reported M.D. Anderson Cancer Center 256 participants Est. completion 2020-12-14 1 site Stand-alone
    Other conditions: Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT01496547

    Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML

    Not yet reported Shanghai Jiao Tong University School of Medicine 47 participants Est. completion 2018-06-30 1 site Stand-alone
    Other conditions: Acute Leukemia
    View official trial listing →
  • Status unknown NCT NCT01498016

    Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia

    Not yet reported Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2022-06 1 site Stand-alone
    Other conditions: Acute Leukemia
    View official trial listing →
  • Completed NCT NCT01499147

    Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

    Not yet reported University of Illinois at Chicago 100 participants Est. completion 2013-05 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Multiple Myeloma, Lymphocytic Leukemia, Myeloproliferative Disorder, Polycythemia Vera, Myelofibrosis, Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT01500161

    Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

    Not yet reported Texas Oncology Cancer Center 1 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Hodgkins Disease, Non-Hodgkins Lymphoma, Aplastic Anemia, Multiple Myeloma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01505569

    Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

    Not yet reported Masonic Cancer Center, University of Minnesota 44 participants Est. completion 2024-02-01 1 site
    Obstructive sleep apnea Other conditions: Ewing's Family Tumors, Renal Tumors, Hepatoblastoma, Soft Tissue Sarcoma, Primary Malignant Brain Neoplasms, Retinoblastoma, Medulloblastoma, Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET), Atypical Teratoid/Rhabdoid Tumor (AT/RT), CNS Tumors, Germ Cell Tumors
    View official trial listing →
  • Suspended NCT NCT01512888

    Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

    Not yet reported, Not yet reported St. Jude Children's Research Hospital 28 participants Est. completion 2034-08 3 sites Stand-alone
    Other conditions: Severe Combined Immunodeficiency Disease, X-linked
    View official trial listing →
  • Terminated NCT NCT01534143

    High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant

    Not yet reported Barbara Ann Karmanos Cancer Institute 1 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01565616

    Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

    Not yet reported Emory University 22 participants Est. completion 2016-06-30 8 sites
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT01572181

    Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens

    Not yet reported Nantes University Hospital 50 participants Est. completion 2017-10-24 15 sites Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT01572662

    Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

    Not yet reported M.D. Anderson Cancer Center 201 participants Est. completion 2022-08-11 1 site Stand-alone
    Other conditions: Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Diseases, Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT01596699

    Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

    Not yet reported University of California, San Francisco 16 participants Est. completion 2019-06 1 site Stand-alone
    Other conditions: Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect, Congenital Immunodeficiency, Metabolic Disease, Severe Immune Dysregulation
    View official trial listing →
  • Completed NCT NCT01605032

    Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

    Not yet reported Albert Einstein College of Medicine 19 participants Est. completion 2018-03 4 sites Stand-alone
    Other conditions: DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT01608204

    Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation

    Rambam Health Care Campus 63 participants Est. completion 2011-12
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT01621477

    T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    Not yet reported St. Jude Children's Research Hospital 34 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hodgkin or Non-Hodgkin Lymphoma, Sarcoma, Myeloid
    View official trial listing →
  • Terminated NCT NCT01622556

    Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies

    Not yet reported University of Virginia 6 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01625351

    A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

    Not yet reported St. Jude Children's Research Hospital 23 participants Est. completion 2020-02-10 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT01629511

    Allogeneic Stem Cell Transplant for CLL

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2018-04-25 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Richter Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT01639690

    ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene

    Not yet reported San Rocco Therapeutics 10 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Confirmed Diagnosis of ß-thalassemia Major
    View official trial listing →
  • Completed NCT NCT01643668

    Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

    Not yet reported Massachusetts General Hospital 34 participants Est. completion 2016-08 3 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT01652092

    Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

    Not yet reported Masonic Cancer Center, University of Minnesota 57 participants Est. completion 2026-12 1 site
    Other conditions: SCID, Omenn's Syndrome, Reticular Dysgenesis, Wiskott-Aldrich Syndrome, Bare Lymphocyte Syndrome, Common Variable Immunodeficiency, Chronic Granulomatous Disease, CD40 Ligand Deficiency, Hyper IgM Syndrome, X-linked Lymphoproliferative Disease, Hemophagocytic Lymphohistiocytosis, Griscelli Syndrome, Chediak-Higashi Syndrome, Langerhan's Cell Histiocytosis
    View official trial listing →
  • Terminated NCT NCT01663766

    Phase I Study of Milatuzumab for Graft Versus Host Disease

    Not yet reported Gilead Sciences 12 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: GVHD (Acute or Chronic), Acute Myeloid or Lymphoblastic Leukemia (AML or ALL), Myelodysplastic Syndrome, Chronic Myelogenous Leukemia (CML), Multiple Myeloma (MM), Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell), Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL)
    View official trial listing →
  • Completed NCT NCT01683123

    Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT

    Grupo Espanol de trasplantes hematopoyeticos y terapia celular 143 participants Est. completion 2012-10
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders, Chronic Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT01685411

    Busulfan and Cyclophosphamide Followed By ALLO BMT

    Not yet reported Masonic Cancer Center, University of Minnesota 5 participants Est. completion 2020-02-10 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01696461

    A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

    Not yet reported Center for International Blood and Marrow Transplant Research 127 participants Est. completion 2016-08 12 sites
    Other conditions: Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01701986

    Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2024-06-05 1 site Stand-alone
    Other conditions: Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01702831

    Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

    Not yet reported University Health Network, Toronto 78 participants Est. completion 2022-07-31 10 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01704716

    High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

    Not yet reported St. Anna Kinderkrebsforschung 3300 participants Est. completion 2026-09 126 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01707004

    Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2017-10-07 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01734850

    Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

    Not yet reported, Not yet reported Calimmune, Inc. 13 participants Est. completion 2017-11 2 sites Stand-alone
    Other conditions: Human Immunodeficiency Virus
    View official trial listing →
  • Terminated NCT NCT01746173

    CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

    Not yet reported Dana-Farber Cancer Institute 5 participants Est. completion 2014-10 2 sites Stand-alone
    Other conditions: T-cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT01749293

    Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation

    Not yet reported University of Illinois at Chicago 3 participants Est. completion 2014-05-15 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01751997

    Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors

    Not yet reported, Not yet reported Byung-Sik Cho 116 participants Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01758328

    Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma

    Not yet reported Memorial Sloan Kettering Cancer Center 29 participants Est. completion 2025-03-17 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01760655

    Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62 participants Est. completion 2022-12-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214, Aplastic Anemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Follicular Lymphoma, Hodgkin Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloid Leukemia, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Polycythemia Vera, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT01766375

    the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient

    Not yet reported Guangxi Medical University 200 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT01773395

    GVAX vs. Placebo for MDS/AML After Allo HSCT

    Not yet reported Dana-Farber Cancer Institute 123 participants Est. completion 2021-11-24 4 sites
    Other conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01779882

    Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

    Not yet reported University Hospital, Basel, Switzerland 72 participants Est. completion 2018-01-06 3 sites Stand-alone
    Other conditions: Myeloid Leukemia, Precursor Myeloid Neoplasms, Lymphoid Neoplasms
    View official trial listing →
  • Completed NCT NCT01785810

    Phase II Maraviroc for GVHD Prevention

    Not yet reported Abramson Cancer Center at Penn Medicine 37 participants Est. completion 2018-07-12 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Status unknown NCT NCT01786018

    Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas

    Not yet reported Azienda Ospedaliera San Giovanni Battista 42 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: B-cell Lymphoma Refractory
    View official trial listing →
  • Withdrawn NCT NCT01795430

    Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

    Not yet reported City of Hope Medical Center 1 site Stand-alone
    Other conditions: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    View official trial listing →
  • Completed NCT NCT01798004

    Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

    Not yet reported Children's Oncology Group 150 participants Est. completion 2024-06-30 123 sites Stand-alone
    Other conditions: Ganglioneuroblastoma, Stage 1 Neuroblastoma, Stage 2 Neuroblastoma, Stage 2A Neuroblastoma, Stage 2B Neuroblastoma, Stage 3 Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT01800643

    Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation

    Not yet reported, Not yet reported Hospital Israelita Albert Einstein 100 participants Est. completion 2014-12 1 site
    Other conditions: Acute Leukemia, Chronic Leukemia, Lymphoproliferative Disease, Myeloproliferative Disease, Immunodeficiency
    View official trial listing →
  • Completed NCT NCT01814475

    Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

    Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 62 participants Est. completion 2016-12-31 21 sites
    Other conditions: Myelofibrosis
    View official trial listing →
  • Completed NCT NCT01814488

    A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

    Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 101 participants Est. completion 2017-06-30 30 sites Stand-alone
    Other conditions: Acute Leukemia
    View official trial listing →
  • Terminated NCT NCT01818479

    Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies

    Not yet reported University of Utah 10 participants Est. completion 2019-04-01 1 site Stand-alone
    Other conditions: High Risk Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01823198

    Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 63 participants Est. completion 2022-05-10 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts Under 20 Percent of Bone Marrow Nucleated Cells, Blasts Under 20 Percent of Peripheral Blood White Cells, Chronic Myelomonocytic Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Therapy-Related Acute Myeloid Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01824693

    Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia

    Not yet reported Children's Oncology Group 30 participants Est. completion 2017-12-31 50 sites Stand-alone
    Other conditions: Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT01828619

    Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients

    Peking University People's Hospital 60 participants 1 site
    Other conditions: Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01852071

    Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene

    Not yet reported, Not yet reported University of California, Los Angeles 46 participants Est. completion 2018-08-27 2 sites Stand-alone
    Other conditions: ADA-SCID
    View official trial listing →
  • Completed NCT NCT01857934

    Therapy for Children With Advanced Stage Neuroblastoma

    Not yet reported St. Jude Children's Research Hospital 153 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01860170

    Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

    Not yet reported, Not yet reported Corewell Health West 28 participants Est. completion 2018-03 1 site
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Completed NCT NCT01883180

    ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

    Not yet reported Nanfang Hospital, Southern Medical University 412 participants Est. completion 2018-01 1 site Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation, Antithymocyte Globulin, Viral Infection
    View official trial listing →
  • Completed NCT NCT01916252

    Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old

    Not yet reported PETHEMA Foundation 460 participants Est. completion 2016-11-16 74 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01923935

    Busulfan and Melphalan Conditioning in Multiple Myeloma

    Not yet reported Chonnam National University Hospital 105 participants Est. completion 2015-12 8 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01959477

    Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

    Not yet reported Case Comprehensive Cancer Center 33 participants Est. completion 2015-04 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage IA Mycosis Fungoides/Sezary Syndrome, Stage IB Mycosis Fungoides/Sezary Syndrome, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IIA Mycosis Fungoides/Sezary Syndrome, Stage IIB Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IIIA Mycosis Fungoides/Sezary Syndrome, Stage IIIB Mycosis Fungoides/Sezary Syndrome, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Stage IVA Mycosis Fungoides/Sezary Syndrome, Stage IVB Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Active, not recruiting NCT NCT01961063

    Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2027-07-06 1 site Stand-alone
    Other conditions: AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma, HIV Infection
    View official trial listing →
  • Active, not recruiting NCT NCT01966367

    CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

    Not yet reported, Not yet reported Diane George 37 participants Est. completion 2030-02 1 site Stand-alone
    Other conditions: Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia, Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Schwachman Diamond Syndrome, Primary Immunodeficiency Syndromes, Acquired Immunodeficiency Syndromes, Histiocytic Syndrome, Familial Hemophagocytic Lymphocytosis, Lymphohistiocytosis, Macrophage Activation Syndrome, Langerhans Cell Histiocytosis (LCH), Hemoglobinopathies, Sickle Cell Disease, Sickle Cell-beta-thalassemia
    View official trial listing →
  • Withdrawn NCT NCT01969942

    A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma

    Not yet reported University of Louisville Est. completion 2016-10 1 site Stand-alone
    Other conditions: Ewing Sarcoma
    View official trial listing →
  • Status unknown NCT NCT01983761

    Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

    Not yet reported, Not yet reported Targazyme, Inc. 25 participants 4 sites Stand-alone
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL), Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01983969

    Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 61 participants Est. completion 2017-11-22 1 site Stand-alone
    Other conditions: Advanced Cancers, Lymphoma
    View official trial listing →
  • Completed NCT NCT01985061

    Evaluation of 3 Different Doses of IV Busulfan

    Not yet reported Institut Paoli-Calmettes 177 participants Est. completion 2026-05-27 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02007863

    Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia

    Not yet reported University of Miami 2 participants Est. completion 2014-06 2 sites Stand-alone
    Other conditions: Leukemia, Myelodysplasia, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia
    View official trial listing →
  • Terminated NCT NCT02025881

    Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma

    Not yet reported, Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 29 participants Est. completion 2020-10-25 13 sites
    Other conditions: High-risk Medulloblastoma
    View official trial listing →
  • Status unknown NCT NCT02034630

    Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD

    Not yet reported, Not yet reported Seoul National University Hospital 5 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Genetic Rare Disease
    View official trial listing →
  • Status unknown NCT NCT02047578

    Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

    Not yet reported Seoul National University Hospital 38 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Withdrawn NCT NCT02053545

    Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion

    Not yet reported, Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago Est. completion 2017-05-11 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, MDS
    View official trial listing →
  • Terminated NCT NCT02057770

    Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported Washington University School of Medicine 25 participants Est. completion 2018-03-23 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute
    View official trial listing →
  • Status unknown NCT NCT02061800

    CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    Not yet reported, Not yet reported Diane George 14 participants Est. completion 2026-07 1 site Stand-alone
    Other conditions: Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphoblastic Leukemia (ALL), Lymphoma (Hodgkin's and Non-Hodgkin's)
    View official trial listing →
  • Completed NCT NCT02063022

    Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma

    Not yet reported Italian Sarcoma Group 278 participants Est. completion 2022-04-14 14 sites Stand-alone
    Other conditions: Ewing's Sarcoma
    View official trial listing →
  • Completed NCT NCT02083250

    Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 70 participants Est. completion 2021-11-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02084563

    Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

    Not yet reported Hospital Israelita Albert Einstein 455 participants Est. completion 2016-11 1 site
    Other conditions: Acute Myeloid Leukemia, Myeloproliferative Neoplasms, Myelodysplastic Syndromes, Myeloproliferative/Myelodysplastic Neoplasm
    View official trial listing →
  • Status unknown NCT NCT02098512

    Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients

    Not yet reported, Not yet reported New York Medical College 20 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Hodgkin Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02114502

    Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma

    Not yet reported M.D. Anderson Cancer Center Stand-alone
    Other conditions: Myeloma
    View official trial listing →
  • Completed NCT NCT02120157

    Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2020-10-01 9 sites Stand-alone
    Other conditions: Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival, Transplantation, Bone Marrow
    View official trial listing →
  • Completed NCT NCT02129582

    Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Case Comprehensive Cancer Center 14 participants Est. completion 2020-03-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelofibrosis, Myeloproliferative Syndrome
    View official trial listing →
  • Completed NCT NCT02130869

    A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas

    Not yet reported St. Jude Children's Research Hospital 8 participants Est. completion 2017-12-20 1 site Stand-alone
    Other conditions: Neuroblastoma, Lymphoma, High-risk Tumor
    View official trial listing →
  • Completed NCT NCT02140554

    A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

    Not yet reported, Not yet reported Genetix Biotherapeutics Inc. 54 participants Est. completion 2024-01-30 11 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02151526

    A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease

    Not yet reported, Not yet reported Genetix Biotherapeutics Inc. 7 participants Est. completion 2019-02-26 1 site Stand-alone
    Other conditions: Beta-Thalassemia Major, Sickle Cell Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02171104

    MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

    Not yet reported Masonic Cancer Center, University of Minnesota 149 participants Est. completion 2029-07-14 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome, Maroteaux Lamy Syndrome, Sly Syndrome, Alpha-Mannosidosis, Fucosidosis, Glycoprotein Metabolic Disorders, Sphingolipidoses, Recessive Leukodystrophies, Globoid Cell Leukodystrophy, Metachromatic Leukodystrophy, Niemann-Pick B, Niemann-Pick C Subtype 2, Sphingomyelin Deficiency, Peroxisomal Disorders, Adrenoleukodystrophy With Cerebral Involvement, Zellweger Syndrome, Neonatal Adrenoleukodystrophy, Infantile Refsum Disease, Acyl-CoA Oxidase Deficiency, D-Bifunctional Enzyme Deficiency, Multifunctional Enzyme Deficiency, Alpha-methylacyl-CoA Racmase Deficiency, Mitochondrial Neurogastrointestingal Encephalopathy, Severe Osteopetrosis, Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation), Inherited Metabolic Disorders
    View official trial listing →
  • Terminated NCT NCT02179359

    Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

    Not yet reported Masonic Cancer Center, University of Minnesota 38 participants Est. completion 2024-11-21 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia, Diamond Blackfan Anemia, Paroxysmal Nocturnal Hemoglobinuria, Glanzmann Thrombasthenia, Severe Congenital Neutropenia, Shwachman-Diamond Syndrome, Non-Malignant Hematologic Disorders
    View official trial listing →
  • Completed NCT NCT02221310

    Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS

    Not yet reported New York Medical College 25 participants Est. completion 2023-04-04 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02248597

    Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

    Not yet reported Wake Forest University Health Sciences 27 participants Est. completion 2023-01-18 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Hematopoietic/Lymphoid Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02250937

    Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 116 participants Est. completion 2027-10-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02251821

    JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center 61 participants Est. completion 2026-01-22 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT02252159

    Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

    Incyte Corporation 2544 participants Est. completion 2019-08-03 266 sites
    Other conditions: MPN (Myeloproliferative Neoplasms)
    View official trial listing →
  • Completed NCT NCT02277639

    Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases

    Not yet reported Children's Hospital of Philadelphia 2 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Bone Marrow Failure Syndromes, Immunodeficiencies, Immune Dysregulation Syndromes
    View official trial listing →
  • Terminated NCT NCT02282904

    Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 7 participants Est. completion 2019-12-10 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Terminated NCT NCT02291965

    Blood Samples to Identify Biomarkers of Busulfan

    Fred Hutchinson Cancer Center 139 participants Est. completion 2024-10-07 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma, Immunodeficiency, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02294552

    Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

    Not yet reported Ivan S Moiseev 200 participants Est. completion 2017-11 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Lymphoma, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Immune System Diseases
    View official trial listing →
  • Terminated NCT NCT02310997

    Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)

    Not yet reported University College, London 11 participants Est. completion 2015-05 12 sites Stand-alone
    Other conditions: Leukaemia, Lymphoma, Other Haematological Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT02323867

    Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies

    Not yet reported Children's Hospital of Philadelphia 140 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplasia
    View official trial listing →
  • Status unknown NCT NCT02328950

    A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome

    Fujian Medical University 50 participants Est. completion 2017-12 1 site
    Other conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma
    View official trial listing →
  • Completed NCT NCT02329080

    New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

    Not yet reported International Extranodal Lymphoma Study Group (IELSG) 79 participants Est. completion 2024-03-22 36 sites Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02333838

    Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies

    Not yet reported Assistance Publique - Hôpitaux de Paris 31 participants Est. completion 2019-05 1 site Stand-alone
    Other conditions: Leukemia, Myeloid
    View official trial listing →
  • Completed NCT NCT02349906

    Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases

    Not yet reported medac GmbH 106 participants Est. completion 2023-02-13 21 sites
    Other conditions: Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies, Bone Marrow Failure Syndromes
    View official trial listing →
  • Terminated NCT NCT02354443

    A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders

    Not yet reported Fate Therapeutics 1 participants Est. completion 2017-02 2 sites
    Other conditions: Metabolic Disorders
    View official trial listing →
  • Status unknown NCT NCT02385955

    Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients

    Not yet reported Seoul National University Hospital 39 participants Est. completion 2019-04 Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Status unknown NCT NCT02386332

    A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies

    Instituto de Investigacion Sanitaria La Fe 206 participants Est. completion 2020-03
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Terminated NCT NCT02410551

    Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

    Not yet reported M.D. Anderson Cancer Center 4 participants Est. completion 2017-01-20 1 site Stand-alone
    Other conditions: Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT02428517

    Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)

    Asan Medical Center 20 participants Est. completion 2016-07 4 sites
    Other conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma
    View official trial listing →
  • Completed NCT NCT02441803

    Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

    Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2021-09-22 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Withdrawn NCT NCT02469974

    Ruxolitinib in Combination With Autotransplant

    Not yet reported Marina Kremyanskaya Est. completion 2016-08 Stand-alone
    Other conditions: Myelofibrosis, MF
    View official trial listing →
  • Completed NCT NCT02472392

    Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma

    Not yet reported University of Louisville 10 participants Est. completion 2016-12 1 site
    Other conditions: EWINGS SARCOMA
    View official trial listing →
  • Completed NCT NCT02483325

    Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases

    Not yet reported Institut Paoli-Calmettes 33 participants Est. completion 2020-03 1 site
    Other conditions: Hematological Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT02500849

    Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

    Not yet reported City of Hope Medical Center 12 participants Est. completion 2027-07-23 5 sites Stand-alone
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02504047

    Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units

    Not yet reported University of Calgary 40 participants Est. completion 2019-02 5 sites Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT02506959

    Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

    Not yet reported M.D. Anderson Cancer Center 83 participants Est. completion 2024-06-03 1 site Stand-alone
    Other conditions: Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT02512497

    Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

    Not yet reported Ohio State University Comprehensive Cancer Center 23 participants Est. completion 2025-06-18 1 site Stand-alone
    Other conditions: Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia, T-Lymphoblastic Leukemia/Lymphoma, Peripheral T-Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02512679

    Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells

    Not yet reported Children's Hospital Los Angeles 20 participants Est. completion 2014-02
    Other conditions: Stem Cell Transplantation, Bone Marrow Transplantation, Peripheral Blood Stem Cell Transplantation, Allogeneic Transplantation, Genetic Diseases, Thalassemia, Pediatrics, Diamond-Blackfan Anemia, Combined Immune Deficiency, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, X-linked Lymphoproliferative Disease, Metabolic Diseases
    View official trial listing →
  • Status unknown NCT NCT02531841

    High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma

    Not yet reported University Hospital Freiburg 250 participants Est. completion 2019-12 2 sites
    Other conditions: Diffuse Large B-cell-lymphoma
    View official trial listing →
  • Status unknown NCT NCT02544425

    VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)

    Not yet reported Samsung Medical Center 27 participants Est. completion 2021-11-30 2 sites Stand-alone
    Other conditions: Extranodal NK-T-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02549586

    Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance

    Not yet reported Gary A Levy, O. Ont. MD. FRCP AGAF 5 participants Est. completion 2020-04-30 2 sites
    Other conditions: Complication of Transplanted Organ, Nos
    View official trial listing →
  • Completed NCT NCT02551718

    High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

    Not yet reported University of Washington 34 participants Est. completion 2021-05-13 1 site Stand-alone
    Other conditions: Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Acute Leukemia of Ambiguous Lineage
    View official trial listing →
  • Withdrawn NCT NCT02577094

    Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia

    Not yet reported, Not yet reported Nantes University Hospital Est. completion 2017-01
    Other conditions: Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT02577926

    The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

    Not yet reported RWTH Aachen University 207 participants Est. completion 2028-12 23 sites
    Other conditions: Polycythemia Vera (PV), Essential Thrombocythemia (ET)
    View official trial listing →
  • Completed NCT NCT02582775

    MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

    Not yet reported Masonic Cancer Center, University of Minnesota 17 participants Est. completion 2023-07-26 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT02589145

    Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 8 participants Est. completion 2019-04-08 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02605460

    Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 20 participants Est. completion 2021-11 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia
    View official trial listing →
  • Completed NCT NCT02623309

    Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

    Not yet reported Institut Paoli-Calmettes 108 participants Est. completion 2021-03-12 14 sites Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT02626715

    Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

    Not yet reported Randy Windreich 21 participants Est. completion 2023-04-12 1 site
    Other conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT)
    View official trial listing →
  • Terminated NCT NCT02627573

    Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

    Not yet reported St. Petersburg State Pavlov Medical University 32 participants Est. completion 2019-04-03 1 site Stand-alone
    Other conditions: Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
    View official trial listing →
  • Active, not recruiting NCT NCT02629120

    High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2028-12-30 1 site
    Other conditions: Chronic Granulomatous Disease Transplant
    View official trial listing →
  • Status unknown NCT NCT02643589

    Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation

    Not yet reported Nanfang Hospital, Southern Medical University 200 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT02660281

    URMC Related Haplo-identical Donor BMT

    Not yet reported University of Rochester 74 participants Est. completion 2021-01-07 1 site
    Other conditions: Hematological Disease, Immune Deficiencies, Solid Tumors, Myelofibrosis, Multiple Myeloma, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02670109

    Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 20 participants Est. completion 2021-11 1 site Stand-alone
    Other conditions: Triple-Negative Invasive Breast Carcinoma, Residual Tumor
    View official trial listing →
  • Completed NCT NCT02670252

    BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT

    Not yet reported Nanfang Hospital, Southern Medical University 550 participants Est. completion 2022-02 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan, Total Body Irradiation, Acute Lymphocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT02670564

    ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

    Not yet reported Swiss Pediatric Oncology Group 1000 participants Est. completion 2026-04 4 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT02671708

    IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 153 participants Est. completion 2020-02-28 1 site Stand-alone
    Other conditions: Autologous Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Conditioning
    View official trial listing →
  • Withdrawn NCT NCT02701673

    Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02724163

    International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

    Not yet reported University of Birmingham 700 participants Est. completion 2032-12 68 sites Stand-alone
    Other conditions: Acute Myeloid Leukaemia
    View official trial listing →
  • Completed NCT NCT02727387

    Protocol for the Treatment of Metastatic Ewing Sarcoma

    Not yet reported Italian Sarcoma Group 155 participants Est. completion 2022-04-29 13 sites Stand-alone
    Other conditions: Ewing's Sarcoma (ES)
    View official trial listing →
  • Terminated NCT NCT02737384

    Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)

    Not yet reported Assistance Publique - Hôpitaux de Paris 4 participants Est. completion 2017-10-26 1 site
    Other conditions: Combined Immunodeficiencies
    View official trial listing →
  • Completed NCT NCT02743351

    Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

    Not yet reported, Not yet reported Fate Therapeutics 96 participants Est. completion 2021-11-05 15 sites Stand-alone
    Other conditions: Hematologic Malignancies, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Acute Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT02744742

    G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 202 participants Est. completion 2021-09-30 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Terminated NCT NCT02750254

    Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

    Not yet reported Washington University School of Medicine 5 participants Est. completion 2020-10-14 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT02759822

    Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

    Leonardo Javier Arcuri 30 participants 1 site
    Other conditions: Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma
    View official trial listing →
  • Completed NCT NCT02766465

    Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

    Not yet reported Medical College of Wisconsin 138 participants Est. completion 2023-08-02 35 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT02766868

    Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL

    Not yet reported Shanghai Jiao Tong University School of Medicine 20 participants Est. completion 2019-07 1 site Stand-alone
    Other conditions: Lymphoblastic Leukemia, Acute, Adult
    View official trial listing →
  • Status unknown NCT NCT02784561

    Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported Chinese PLA General Hospital 80 participants Est. completion 2020-07 Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT02788201

    Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma

    Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2019-10-23 1 site Stand-alone
    Other conditions: Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms
    View official trial listing →
  • Completed NCT NCT02793544

    HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

    Not yet reported Center for International Blood and Marrow Transplant Research 80 participants Est. completion 2020-03 11 sites
    Other conditions: Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemotherapy-sensitive Lymphoma, Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma, Acute Myelogenous Leukemia (AML), Acute Biphenotypic Leukemia (ABL), Acute Undifferentiated Leukemia (AUL)
    View official trial listing →
  • Completed NCT NCT02799147

    GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

    Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 27 participants Est. completion 2020-11 1 site Stand-alone
    Other conditions: Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias
    View official trial listing →
  • Completed NCT NCT02806375

    PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

    Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 20 participants Est. completion 2019-04 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Myeloproliferative Disorders
    View official trial listing →
  • Status unknown NCT NCT02836639

    BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma

    Not yet reported Pusan National University Hospital 20 participants 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Active, not recruiting NCT NCT02861417

    Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 204 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Lymphoproliferative Disorder, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent High Risk Myelodysplastic Syndrome, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT02876679

    Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

    Not yet reported Assistance Publique - Hôpitaux de Paris 94 participants Est. completion 2020-10-12 1 site Stand-alone
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02906202

    A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

    Not yet reported Genetix Biotherapeutics Inc. 24 participants Est. completion 2022-03-31 8 sites Stand-alone
    Other conditions: Beta-Thalassemia
    View official trial listing →
  • Completed NCT NCT02916979

    Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

    Not yet reported Dartmouth-Hitchcock Medical Center 20 participants Est. completion 2022-02-11 1 site
    Other conditions: Leukemia, Lymphoid, Leukemia, Myeloid, Myelodysplastic Syndromes, Myelofibrosis, Lymphoma, Malignant, Multiple Myeloma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Active, not recruiting NCT NCT02928991

    Fludarabine Based RIC for Bone Marrow Failure Syndromes

    Not yet reported Children's Hospital of Philadelphia 25 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Bone Marrow Failure Syndromes
    View official trial listing →
  • Status unknown NCT NCT02938741

    ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 130 participants Est. completion 2022-12 2 sites Stand-alone
    Other conditions: Lymphoblastic Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02961816

    Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma

    Not yet reported M.D. Anderson Cancer Center Est. completion 2021-06 Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02990819

    Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

    Not yet reported Children's Hospital of Philadelphia 60 participants Est. completion 2027-12 1 site
    Other conditions: Immunodeficiencies, Immune Dysregulation Syndromes
    View official trial listing →
  • Completed NCT NCT02999984

    Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

    Not yet reported, Not yet reported University of California, Los Angeles 10 participants Est. completion 2019-09-26 1 site Stand-alone
    Other conditions: Severe Combined Immunodeficiency Due to ADA Deficiency
    View official trial listing →
  • Completed NCT NCT03011528

    First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)

    Not yet reported Institut Curie 45 participants Est. completion 2023-11 17 sites
    Other conditions: Ewing Sarcoma Family of Tumors
    View official trial listing →
  • Completed NCT NCT03018223

    Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 32 participants Est. completion 2021-03-18 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia, Primary Myelofibrosis, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Hodgkin Lymphoma, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT03035422

    Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 24 participants Est. completion 2021-12-18 1 site
    Other conditions: Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT03079089

    Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40 participants Est. completion 2023-09-11 1 site
    Other conditions: Refractory or Relapsed Lymphoid Haemopathy
    View official trial listing →
  • Completed NCT NCT03096782

    Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2022-09-20 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chemotherapy-Related Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Langerhans Cell Histiocytosis, Minimal Residual Disease, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Myelodysplastic Syndrome, Small Lymphocytic Lymphoma, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT03121014

    Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

    Not yet reported University of Illinois at Chicago 38 participants Est. completion 2026-04 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT03128359

    High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

    Not yet reported City of Hope Medical Center 38 participants Est. completion 2021-09-15 1 site Stand-alone
    Other conditions: Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Graft Versus Host Disease, Hodgkin Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Secondary Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT03151876

    Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma

    Not yet reported Sichuan University 93 participants Est. completion 2021-12 18 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03171831

    Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major

    Not yet reported First Affiliated Hospital of Guangxi Medical University 30 participants Est. completion 2022-04-01 1 site Stand-alone
    Other conditions: Thalassemia Major
    View official trial listing →
  • Status unknown NCT NCT03190733

    A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

    Not yet reported Zhujiang Hospital 192 participants Est. completion 2021-09-30 Stand-alone
    Other conditions: Chronic Graft-versus-host-disease, Leukemia Relapse
    View official trial listing →
  • Completed NCT NCT03207009

    A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia

    Not yet reported Genetix Biotherapeutics Inc. 19 participants Est. completion 2022-11-15 9 sites Stand-alone
    Other conditions: Beta-Thalassemia
    View official trial listing →
  • Status unknown NCT NCT03229616

    BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 122 participants Est. completion 2020-06 1 site Stand-alone
    Other conditions: Autologous Hematopoietic Stem Cell Transplantation, Diffuse Large B-cell Lymphoma, Conditioning
    View official trial listing →
  • Status unknown NCT NCT03235973

    Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

    Not yet reported Institut Paoli-Calmettes 29 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute
    View official trial listing →
  • Terminated NCT NCT03240861

    Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer

    Not yet reported Jonsson Comprehensive Cancer Center 5 participants Est. completion 2023-10-19 1 site Stand-alone
    Other conditions: HLA-A*0201 Positive Cells Present, Locally Advanced Malignant Neoplasm, NY-ESO-1 Positive, Unresectable Malignant Neoplasm, Sarcoma
    View official trial listing →
  • Status unknown NCT NCT03246178

    Haploidentical Transplantation in Severe Aplastic Anemia

    Not yet reported Wu Xiaoxiong 60 participants Est. completion 2020-12-01 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT03247088

    Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 74 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT03256071

    Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 90 participants Est. completion 2021-09 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Completed NCT NCT03259503

    Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 50 participants Est. completion 2025-11-05 1 site Stand-alone
    Other conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT03270748

    Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

    Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 78 participants Est. completion 2022-11-20 33 sites Stand-alone
    Other conditions: Myeloid Malignancies
    View official trial listing →
  • Terminated NCT NCT03303950

    Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

    Not yet reported University of Utah 6 participants Est. completion 2020-02-19 1 site Stand-alone
    Other conditions: Anemia, ASXL1 Gene Mutation, EZH2 Gene Mutation, IDH1 Gene Mutation, IDH2 Gene Mutation, Plasma Cell Myeloma, Primary Myelofibrosis, Recurrent Plasma Cell Myeloma, Secondary Myelofibrosis, Thrombocytopenia
    View official trial listing →
  • Status unknown NCT NCT03315078

    Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 13 participants Est. completion 2022-12 1 site Stand-alone
    Other conditions: X-Linked Combined Immunodeficiency Diseases
    View official trial listing →
  • Status unknown NCT NCT03337568

    Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission

    Asan Medical Center 110 participants Est. completion 2021-03-30 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT03339700

    Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 15 participants Est. completion 2021-09 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Adult
    View official trial listing →
  • Status unknown NCT NCT03384212

    CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2022-07-31 1 site Stand-alone
    Other conditions: High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT03384225

    CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2022-07-31 1 site Stand-alone
    Other conditions: High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT03385096

    Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 122 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Autologous Hematopoietic Stem Cell Transplantation, Conditioning, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT03392987

    A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)

    Not yet reported Orchard Therapeutics 10 participants Est. completion 2026-03-10 1 site Stand-alone
    Other conditions: Lysosomal Storage Disease, Metachromatic Leukodystrophy
    View official trial listing →
  • Status unknown NCT NCT03412266

    RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT

    Not yet reported Peking University People's Hospital 50 participants Est. completion 2023-03-01 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT03412409

    RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

    Not yet reported Peking University People's Hospital 50 participants Est. completion 2025-09-01 1 site Stand-alone
    Other conditions: Acute Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT03432364

    A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)

    Not yet reported, Not yet reported Sangamo Therapeutics 5 participants Est. completion 2022-11-17 6 sites Stand-alone
    Other conditions: Transfusion Dependent Beta-thalassemia
    View official trial listing →
  • Terminated NCT NCT03456817

    HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis

    Not yet reported AHS Cancer Control Alberta 68 participants Est. completion 2025-05-31 1 site Stand-alone
    Other conditions: Graft-versus-host-disease, Relapse
    View official trial listing →
  • Completed NCT NCT03492749

    Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation

    Hospital Israelita Albert Einstein 80 participants Est. completion 2020-08
    Other conditions: Bone Marrow Disease
    View official trial listing →
  • Completed NCT NCT03513328

    Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

    Not yet reported, Not yet reported University of Florida 6 participants Est. completion 2023-02-19 1 site Stand-alone
    Other conditions: Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Acquired Neutropenia in Newborn, Acquired Anemia Hemolytic, Acquired Thrombocytopenia, Hemophagocytic Lymphohistiocytoses, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, Common Variable Immunodeficiency, X-linked Lymphoproliferative Disease, Severe Combined Immunodeficiency, Hurler Syndrome, Mannosidosis, Adrenoleukodystrophy
    View official trial listing →
  • Withdrawn NCT NCT03515707

    Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2022-07-30 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Minimal Residual Disease Negativity
    View official trial listing →
  • Status unknown NCT NCT03517631

    An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.

    Not yet reported Shanghai Public Health Clinical Center 6 participants Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: HIV Infections, AIDS
    View official trial listing →
  • Status unknown NCT NCT03530085

    Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 60 participants Est. completion 2022-04-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning, Elderly
    View official trial listing →
  • Status unknown NCT NCT03583294

    A Study on the Uterus, Ovarian and Reproductive Functions According to Conditioning Regimen and Pubertal Status at the Time of Stem Cell Transplantation in a Leukemia Pediatric Population

    Not yet reported Assistance Publique Hopitaux De Marseille 212 participants Est. completion 2021-04-01 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT03596892

    Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 122 participants Est. completion 2022-06 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Conditions, Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT03597594

    Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)

    Not yet reported, Not yet reported St. Jude Children's Research Hospital 4 participants Est. completion 2028-07-01 1 site
    Other conditions: Severe Combined Immunodeficiency
    View official trial listing →
  • Terminated NCT NCT03600909

    A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

    Not yet reported Memorial Sloan Kettering Cancer Center 3 participants Est. completion 2021-04-09 3 sites Stand-alone
    Other conditions: Fanconi Anemia, Myelodysplastic Syndrome (MDS), Acute Myelogenous Leukemia (AML)
    View official trial listing →
  • Status unknown NCT NCT03601286

    Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency

    Not yet reported Great Ormond Street Hospital for Children NHS Foundation Trust 5 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Severe Combined Immunodeficiency, X-Linked
    View official trial listing →
  • Status unknown NCT NCT03602131

    Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma

    Not yet reported Sichuan University 30 participants Est. completion 2021-03-30 Stand-alone
    Other conditions: Hodgkin Lymphoma, Non-hodgkin Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT03602898

    Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2023-09-17 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT03613532

    Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

    Not yet reported Jacqueline Garcia, MD 102 participants Est. completion 2030-03-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable), Hematopoietic Stem Cell Transplant
    View official trial listing →
  • Terminated NCT NCT03615105

    Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

    Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2024-03-06 1 site Stand-alone
    Other conditions: Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT03619551

    Conditioning SCID Infants Diagnosed Early

    Not yet reported Center for International Blood and Marrow Transplant Research 56 participants Est. completion 2028-12-01 40 sites Stand-alone
    Other conditions: SCID
    View official trial listing →
  • Completed NCT NCT03653247

    A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease

    Not yet reported, Not yet reported Sangamo Therapeutics 7 participants Est. completion 2025-07-17 5 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT03655678

    A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia

    Not yet reported, Not yet reported Vertex Pharmaceuticals Incorporated 59 participants Est. completion 2025-11-13 14 sites Stand-alone
    Other conditions: Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn, Hematologic Diseases, Hemoglobinopathies
    View official trial listing →
  • Active, not recruiting NCT NCT03663933

    Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

    Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2030-04-03 2 sites Stand-alone
    Other conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders, Immune System Diseases, Common Variable Immunodeficiency
    View official trial listing →
  • Active, not recruiting NCT NCT03674411

    Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

    Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Biphenotypic/Undifferentiated Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Relapsed Large Cell Lymphoma, Mantle Cell Lymphoma, Hodgkin Lymphoma, Burkitt Lymphoma, Relapsed T-Cell Lymphoma, Lymphoplasmacytic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03687463

    Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

    Capital Research Institute of Pediatrics 6 participants Est. completion 2020-04-10
    Other conditions: Hematopoietic System--Cancer
    View official trial listing →
  • Status unknown NCT NCT03733327

    BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 20 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma, Autologous Hematopoietic Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Completed NCT NCT03745287

    A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

    Not yet reported, Not yet reported Vertex Pharmaceuticals Incorporated 63 participants Est. completion 2025-07-07 17 sites Stand-alone
    Other conditions: Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies
    View official trial listing →
  • Completed NCT NCT03765632

    Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

    Not yet reported, Not yet reported Great Ormond Street Hospital for Children NHS Foundation Trust 13 participants Est. completion 2022-09-28 1 site Stand-alone
    Other conditions: Severe Combined Immunodeficiency Due to ADA Deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT03779854

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 45 participants Est. completion 2027-08-31 9 sites Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blasts Under 25 Percent of Bone Marrow Nucleated Cells, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome/Acute Myeloid Leukemia, Burkitt Leukemia, Chronic Monocytic Leukemia, Lymphoblastic Lymphoma, Mast Cell Leukemia, Myeloproliferative Neoplasm
    View official trial listing →
  • Completed NCT NCT03792815

    Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL)

    Not yet reported Soonchunhyang University Hospital 51 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT03794167

    BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

    Not yet reported Soonchunhyang University Hospital 75 participants Est. completion 2018-11-30 1 site Stand-alone
    Other conditions: Non-hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03795597

    Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

    Not yet reported, Not yet reported Loyola University 36 participants Est. completion 2023-11-01 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT03799224

    Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

    Not yet reported, Not yet reported Peking University People's Hospital 55 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Stem Cell Transplant Complications, Relapse Leukemia, Refractory Leukemia
    View official trial listing →
  • Status unknown NCT NCT03821987

    Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA

    Not yet reported Peking University People's Hospital 55 participants Est. completion 2022-03-30 1 site Stand-alone
    Other conditions: Aplastic Anemia, Stem Cell Transplant Complications, Engraft Failure
    View official trial listing →
  • Completed NCT NCT03852498

    A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

    Not yet reported Genetix Biotherapeutics Inc. 35 participants Est. completion 2023-07-24 8 sites Stand-alone
    Other conditions: Cerebral Adrenoleukodystrophy (CALD)
    View official trial listing →
  • Completed NCT NCT03902665

    Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 19 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Adult
    View official trial listing →
  • Active, not recruiting NCT NCT03910452

    Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4 participants Est. completion 2034-06-15 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03922724

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 91 participants Est. completion 2030-10-31 2 sites Stand-alone
    Other conditions: Peripheral T-cell Lymphomas, Lymphoproliferative Disorders, Immune System Diseases
    View official trial listing →
  • Status unknown NCT NCT03955601

    A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia:

    Not yet reported National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 30 participants Est. completion 2021-06-30 1 site
    Other conditions: Aplastic Anemia Idiopathic
    View official trial listing →
  • Active, not recruiting NCT NCT03983850

    Optimizing PTCy Dose and Timing

    Not yet reported, Not yet reported National Cancer Institute (NCI) 105 participants Est. completion 2026-10-26 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Hematologic Neoplasms
    View official trial listing →
  • Terminated NCT NCT04002115

    Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML

    Not yet reported Milton S. Hershey Medical Center 2 participants Est. completion 2022-11-07 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT04009525

    Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

    Not yet reported First Affiliated Hospital of Guangxi Medical University 823 participants Est. completion 2023-10-31 1 site Stand-alone
    Other conditions: Thalassemia Major
    View official trial listing →
  • Terminated NCT NCT04067180

    Randomized Clinical Study Assessing Haplo vs. URD in AML

    Not yet reported Karolinska Institutet 18 participants Est. completion 2022-08-26 9 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT04098393

    Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

    Not yet reported Memorial Sloan Kettering Cancer Center 39 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT04098653

    Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 196 participants Est. completion 2023-08 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning, Myeloid Tumors
    View official trial listing →
  • Status unknown NCT NCT04123392

    Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 196 participants Est. completion 2023-09 1 site Stand-alone
    Other conditions: TP53, Myeloid Tumors, Conditioning, Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Withdrawn NCT NCT04127721

    Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center Est. completion 2020-09-22 1 site Stand-alone
    Other conditions: Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT04151706

    CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML

    Not yet reported Robert Lowsky 7 participants Est. completion 2023-09-08 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Acute Leukemia, Chronic Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT04217278

    A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

    Not yet reported, Not yet reported University of Birmingham 333 participants Est. completion 2026-05 14 sites
    Other conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT04220008

    Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma

    Not yet reported M.D. Anderson Cancer Center Est. completion 2021-10-29 Stand-alone
    Other conditions: Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT04269811

    Flu-Bu-Mel Conditioning Regimen for Myeloid Disease

    Not yet reported Shanghai Jiao Tong University School of Medicine 49 participants Est. completion 2023-06-30 2 sites Stand-alone
    Other conditions: Relapse Rate After Allo-HSCT
    View official trial listing →
  • Withdrawn NCT NCT04282174

    CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

    Not yet reported Baptist Health South Florida Est. completion 2030-03-01 1 site Stand-alone
    Other conditions: Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT04293185

    A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

    Not yet reported Genetix Biotherapeutics Inc. 35 participants Est. completion 2027-11 9 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Withdrawn NCT NCT04370795

    Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2025-11-26 1 site
    Other conditions: Severe Combined Immune Deficiency (SCID)
    View official trial listing →
  • Active, not recruiting NCT NCT04384692

    Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2030-04-23 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Not yet recruiting NCT NCT04418414

    Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

    Not yet reported Expression Therapeutics, LLC 7 participants Est. completion 2039-08 Stand-alone
    Other conditions: Hemophilia A
    View official trial listing →
  • Not yet recruiting NCT NCT04451200

    Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

    Not yet reported Institut Paoli-Calmettes 82 participants Est. completion 2028-12 Stand-alone
    Other conditions: Acute Leukemia, Mielodysplasic Syndrome, Myeloproliferative Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT04547049

    A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

    Not yet reported First Affiliated Hospital of Zhejiang University 232 participants Est. completion 2026-04-01 8 sites
    Other conditions: Leukemia, MDS
    View official trial listing →
  • Status unknown NCT NCT04582604

    Ruxolitinib and Decitabine for High Risk Hematological Malignancies

    Not yet reported, Not yet reported Chinese PLA General Hospital 60 participants Est. completion 2025-09-30 1 site Stand-alone
    Other conditions: Peripheral Blood Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT04669210

    PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT

    Not yet reported St. Petersburg State Pavlov Medical University 128 participants Est. completion 2025-03-28 2 sites Stand-alone
    Other conditions: Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoid Leukemia
    View official trial listing →
  • Status unknown NCT NCT04688021

    A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

    Not yet reported Yi Luo 46 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Leukemia, Graft-versus-host-disease
    View official trial listing →
  • Completed NCT NCT04690192

    CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma

    Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 30 participants Est. completion 2024-12-30 1 site Stand-alone
    Other conditions: Large B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04713956

    G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 242 participants Est. completion 2024-07-31 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Withdrawn NCT NCT04776850

    Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

    Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-05 Stand-alone
    Other conditions: Beta Thalassemia Major, Sickle Beta 0 Thalassemia, Sickle Beta Plus Thalassemia, Sickle Beta Thalassemia, Sickle Cell Disease, Sickle Cell-SS Disease
    View official trial listing →
  • Status unknown NCT NCT04786002

    Target Busulfan Exposure in Children With HSCT in China

    The First Affiliated Hospital of Soochow University 500 participants Est. completion 2023-06-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT04822532

    Precision Dosing of Busulfan in Children Undergoing HSCT

    Not yet reported University Hospital, Geneva 260 participants Est. completion 2025-06 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Autologous Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT04853576

    A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

    Not yet reported, Not yet reported Editas Medicine, Inc. 45 participants Est. completion 2025-08 24 sites Stand-alone
    Other conditions: Sickle Cell Disease, Hemoglobinopathies
    View official trial listing →
  • Active, not recruiting NCT NCT04859946

    Itacitinib for the Prevention of Graft Versus Host Disease

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2027-04-01 1 site Stand-alone
    Other conditions: Hematologic and Lymphocytic Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT04872595

    A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

    Not yet reported Memorial Sloan Kettering Cancer Center 59 participants Est. completion 2027-04 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), Myelodysplastic Syndromes (MDS)
    View official trial listing →
  • Status unknown NCT NCT04897139

    Flu-Bu-Mel Based Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allo-HSCT

    Not yet reported Shanghai Jiao Tong University School of Medicine 23 participants Est. completion 2024-12-01 1 site Stand-alone
    Other conditions: Lymphoid Neoplasm
    View official trial listing →
  • Status unknown NCT NCT04904237

    Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.

    Not yet reported Shanghai Jiao Tong University School of Medicine 23 participants Est. completion 2024-06-01 3 sites
    Other conditions: Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT04904588

    HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

    Not yet reported Center for International Blood and Marrow Transplant Research 300 participants Est. completion 2026-12 39 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT04925206

    A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

    Not yet reported EdiGene (GuangZhou) Inc. 8 participants Est. completion 2025-03-12 4 sites Stand-alone
    Other conditions: Transfusion Dependent Beta-Thalassaemia
    View official trial listing →
  • Completed NCT NCT04942730

    Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

    Not yet reported St. Petersburg State Pavlov Medical University 50 participants Est. completion 2024-04-30 1 site Stand-alone
    Other conditions: Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Neoplasm
    View official trial listing →
  • Status unknown NCT NCT04945096

    Outcomes of Patients After Allo-HSCT With Decitabine and NAC

    Not yet reported The First Affiliated Hospital of Soochow University 100 participants Est. completion 2025-12-01 Stand-alone
    Other conditions: Engraft Failure, Relapse, GVHD
    View official trial listing →
  • Withdrawn NCT NCT04982354

    Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia

    Not yet reported, Not yet reported Guenther Koehne Est. completion 2032-08-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT04990323

    US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies

    Not yet reported, Not yet reported ExCellThera inc. 13 participants Est. completion 2025-12-31 1 site
    Other conditions: High Risk Myeloid Malignancies, Cord Blood Transplant
    View official trial listing →
  • Completed NCT NCT05015920

    A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants

    Not yet reported Shanghai BDgene Co., Ltd. 2 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Status unknown NCT NCT05075681

    Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma

    Not yet reported, Not yet reported Chinese PLA General Hospital 50 participants Est. completion 2025-06-01 1 site Stand-alone
    Other conditions: Peripheral Blood Stem Cell Transplantation
    View official trial listing →
  • Withdrawn NCT NCT05170828

    Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

    Not yet reported Ossium Health, Inc. Est. completion 2024-11
    Other conditions: Acute Leukemia, Myelodysplastic Syndromes, T-lymphoblastic Lymphoma, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia
    View official trial listing →
  • Status unknown NCT NCT05250362

    Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

    Not yet reported, Not yet reported Sichuan University 56 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Withdrawn NCT NCT05293509

    Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

    Not yet reported M.D. Anderson Cancer Center Est. completion 2023-09-18 1 site Stand-alone
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT05303727

    Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Active, not recruiting NCT NCT05329649

    Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

    Not yet reported Vertex Pharmaceuticals Incorporated 13 participants Est. completion 2027-06-06 7 sites Stand-alone
    Other conditions: Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance, Hemoglobinopathies, Hematological Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT05356195

    Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

    Not yet reported Vertex Pharmaceuticals Incorporated 16 participants Est. completion 2027-11-14 6 sites Stand-alone
    Other conditions: Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn, Hematologic Diseases, Hemoglobinopathies
    View official trial listing →
  • Status unknown NCT NCT05425654

    RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

    Not yet reported National Research Center for Hematology, Russia 30 participants Est. completion 2026-05 1 site Stand-alone
    Other conditions: Primary CNS Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT05432310

    Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector

    Not yet reported, Not yet reported University of California, Los Angeles 20 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Adenosine Deaminase Severe Combined Immune Deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT05444894

    EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

    Not yet reported, Not yet reported Editas Medicine, Inc. 9 participants Est. completion 2025-12 8 sites Stand-alone
    Other conditions: Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major, Thalassemia Intermedia
    View official trial listing →
  • Status unknown NCT NCT05449899

    G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 232 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Status unknown NCT NCT05453552

    G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 242 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Active, not recruiting NCT NCT05456880

    BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease

    Not yet reported, Not yet reported Beam Therapeutics Inc. 15 participants Est. completion 2028-02 19 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05457556

    Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

    Not yet reported Children's Oncology Group 66 participants Est. completion 2027-07-07 63 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT05466318

    ChiCGB vs BEAM in High-risk or R/R Lymphomas

    Not yet reported Sichuan University 306 participants Est. completion 2025-12-30 11 sites Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell
    View official trial listing →
  • Status unknown NCT NCT05510505

    GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT

    Not yet reported The First Affiliated Hospital of Soochow University 100 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Not yet recruiting NCT NCT05565105

    CD34+ Transplants for Leukemia and Lymphoma

    Not yet reported Guenther Koehne 100 participants Est. completion 2033-06 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute
    View official trial listing →
  • Terminated NCT NCT05569512

    Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML

    Not yet reported Malika Kapadia 1 participants Est. completion 2023-12-06 5 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Pediatric Cancer
    View official trial listing →
  • Terminated NCT NCT05579769

    Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

    Not yet reported St. Jude Children's Research Hospital 3 participants Est. completion 2024-05-08 1 site Stand-alone
    Other conditions: Hematologic Malignancy, Myeloid Malignancy
    View official trial listing →
  • Status unknown NCT NCT05583175

    Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

    Not yet reported Xianmin Song, MD 50 participants Est. completion 2024-11-01 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation, Myeloid Malignancy
    View official trial listing →
  • Active, not recruiting NCT NCT05589896

    A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

    Not yet reported, Not yet reported Ossium Health, Inc. 12 participants Est. completion 2029-05-31 9 sites Stand-alone
    Other conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia, CLL (Chronic Lymphocytic Leukemia), Chronic Myeloid Leukemia (CML), MDS (Myelodysplastic Syndrome), Non-Hodgkin Lymphomas, Hodgkins Lymphoma, Cutaneous T Cell Lymphomas (CTCL)
    View official trial listing →
  • Status unknown NCT NCT05598593

    Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL

    Not yet reported First Affiliated Hospital of Zhejiang University 70 participants Est. completion 2025-09 1 site Stand-alone
    Other conditions: Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    View official trial listing →
  • Suspended NCT NCT05617625

    CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome

    Not yet reported Guenther Koehne 50 participants Est. completion 2033-06 1 site Stand-alone
    Other conditions: Myelodysplastic Syndromes, Graft Vs Host Disease, Graft-versus-host-disease
    View official trial listing →
  • Status unknown NCT NCT05667402

    Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 50 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Central Nervous System Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Enrolling by invitation NCT NCT05674539

    Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200 participants Est. completion 2025-12-30 1 site
    Other conditions: Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT05739630

    M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 60 participants Est. completion 2025-01-31 1 site
    Other conditions: Acute Leukemia
    View official trial listing →
  • Status unknown NCT NCT05807659

    Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies

    Not yet reported Sichuan University 18 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Myeloid Malignancies
    View official trial listing →
  • Status unknown NCT NCT05814731

    Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 264 participants Est. completion 2025-12-31 1 site
    Other conditions: Haploidentical Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Status unknown NCT NCT05907486

    The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation

    Not yet reported The First Affiliated Hospital of Soochow University 260 participants Est. completion 2025-12-01 Stand-alone
    Other conditions: Thrombotic Disorder
    View official trial listing →
  • Status unknown NCT NCT05929092

    TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological Diseases

    Not yet reported The First Affiliated Hospital of Soochow University 40 participants Est. completion 2026-05-31 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases
    View official trial listing →
  • Withdrawn NCT NCT05951205

    Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC Genotype

    Not yet reported Vertex Pharmaceuticals Incorporated Est. completion 2033-12-31 Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Active, not recruiting NCT NCT06001385

    HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

    Not yet reported Center for International Blood and Marrow Transplant Research 313 participants Est. completion 2026-12-30 32 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Neoplasm, Lymphoma, Chronic Myelomonocytic Leukemia, Pro-Lymphocytic Leukemia, Myelofibrosis
    View official trial listing →
  • Status unknown NCT NCT06069180

    The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA

    Not yet reported Peking University People's Hospital 160 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT06079879

    A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

    Not yet reported Merck Sharp & Dohme LLC 340 participants Est. completion 2028-08-18 161 sites
    Other conditions: Essential Thrombocythemia
    View official trial listing →
  • Status unknown NCT NCT06111625

    Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL

    Not yet reported Sichuan University 20 participants Est. completion 2026-08-31 1 site Stand-alone
    Other conditions: Leukemia, Lymphoid
    View official trial listing →
  • Not yet recruiting NCT NCT06133556

    Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 237 participants Est. completion 2028-10-20
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT06149403

    A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT

    Not yet reported Orchard Therapeutics 41 participants Est. completion 2031-03 5 sites Stand-alone
    Other conditions: MPS-IH (Hurler Syndrome)
    View official trial listing →
  • Not yet recruiting NCT NCT06228781

    Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis

    Not yet reported Tianjin Medical University General Hospital 20 participants Est. completion 2029-01-01
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT06247917

    Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS

    Not yet reported Ruijin Hospital 59 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT06279338

    A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2026-01-31 Stand-alone
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Not yet recruiting NCT NCT06297772

    Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

    Not yet reported Ruijin Hospital 220 participants Est. completion 2028-05-01 1 site Stand-alone
    Other conditions: AML, Adult
    View official trial listing →
  • Withdrawn NCT NCT06337331

    Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

    Not yet reported Northside Hospital, Inc. Est. completion 2027-08-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Not yet recruiting NCT NCT06385808

    Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 37 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Relapse Leukemia, Refractory Acute Myeloid Leukemia, Conditioning, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT06468267

    RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

    Not yet reported Xianmin Song, MD 50 participants Est. completion 2026-07-15 1 site Stand-alone
    Other conditions: Peripheral T Cell Lymphoma
    View official trial listing →
  • Enrolling by invitation NCT NCT06559176

    A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )

    Not yet reported, Not yet reported Prime Medicine, Inc. 12 participants Est. completion 2030-02 5 sites Stand-alone
    Other conditions: Chronic Granulomatous Disease, Granulomatous Disease, Chronic
    View official trial listing →
  • Not yet recruiting NCT NCT06613035

    Twice-per-weekSelinexor, 2 Days Melphalan

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 126 participants Est. completion 2027-09-30 4 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT06625359

    High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma

    Not yet reported Seoul National University Hospital 17 participants Est. completion 2024-09-30 1 site
    Other conditions: Central Nervous System Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06673459

    BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

    Not yet reported The First Affiliated Hospital of Soochow University 430 participants Est. completion 2029-11-30 1 site
    Other conditions: T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Total Body Irradiation, Chemotherapy
    View official trial listing →
  • Not yet recruiting NCT NCT06741813

    Allo-HSCT vs ASCT in Adult T-LBL

    Not yet reported Peking University People's Hospital 230 participants Est. completion 2029-12-31 Stand-alone
    Other conditions: T Lymphoblastic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT06758726

    Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 20 participants Est. completion 2026-10-01
    Other conditions: AML
    View official trial listing →
  • Enrolling by invitation NCT NCT06851767

    Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 18 participants Est. completion 2034-12-31 1 site Stand-alone
    Other conditions: X-linked Severe Combined Immunodeficiency, X-SCID, XSCID
    View official trial listing →
  • Not yet recruiting NCT NCT06900192

    A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

    Not yet reported Stanford University 10 participants Est. completion 2029-08 Stand-alone
    Other conditions: Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
    View official trial listing →
  • Not yet recruiting NCT NCT06954987

    Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

    Not yet reported National Cancer Institute (NCI) 244 participants Est. completion 2028-05-15 Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Not yet recruiting NCT NCT07052422

    VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 160 participants Est. completion 2029-12-31 Stand-alone
    Other conditions: Older Patients, Myeloid Malignancies, Conditioning, Hematopoietic Stem Cell Transplantation (HSCT)
    View official trial listing →
  • Not yet recruiting NCT NCT07085156

    Reduced Intensity Conditioning for MDS

    Not yet reported Ruijin Hospital 45 participants Est. completion 2028-05-01 1 site Stand-alone
    Other conditions: MDS
    View official trial listing →
  • Enrolling by invitation NCT NCT07113743

    Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2029-09-01 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease (CGD)
    View official trial listing →
  • Completed NCT NCT07155382

    Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1

    Asan Medical Center 98 participants Est. completion 2024-08-22 1 site
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Not yet recruiting NCT NCT07276737

    Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 37 participants Est. completion 2029-12-30 Stand-alone
    Other conditions: NK T-Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07441967

    The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 44 participants Est. completion 2028-12-30 Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Not yet recruiting NCT NCT07524530

    Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

    Not yet reported National Cancer Institute (NCI) 102 participants Est. completion 2036-06-01 1 site Stand-alone
    Other conditions: Core Binding Factor Alpha Subunits, Hematologic Neoplasms, Leukemia, Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07562568

    SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

    Not yet reported The First Affiliated Hospital of Soochow University 160 participants Est. completion 2030-06 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554, Azacytidine
    View official trial listing →
  • Not yet recruiting NCT NCT07563920

    TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93 participants Est. completion 2030-06 Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Not yet recruiting NCT NCT07572695

    Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12
    Other conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/Refractory
    View official trial listing →
  • Not yet recruiting NCT NCT07575412

    SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

    Not yet reported The First Affiliated Hospital of Soochow University 180 participants Est. completion 2030-06 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554, Azacytidine
    View official trial listing →
  • Not yet recruiting NCT NCT07644481

    Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 30 participants Est. completion 2029-12-31 Stand-alone
    Other conditions: AML (Acute Myelogenous Leukemia), Allogeneic Hematopoietic Stem Cell Transplantation Recipient
    View official trial listing →
  • Not yet recruiting NCT NCT07737769

    Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Not yet reported University of Michigan Rogel Cancer Center 20 participants Est. completion 2029-11 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07759102

    Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma

    Not yet reported University of California, Davis 20 participants Est. completion 2033-09-01 1 site Stand-alone
    Other conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma
    View official trial listing →
  • Not yet recruiting NCT NCT07762508

    A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients

    Not yet reported The First Affiliated Hospital of Soochow University 42 participants Est. completion 2029-07 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute(AML), Hematopoietic Stem Cell Transplantation (HSCT)
    View official trial listing →
  • Enrolling by invitation NCT NCT07775313

    Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2033-12-31 1 site Stand-alone
    Other conditions: WHIM, Warts, Hypogammaglobulinemia, Immunodeficiency, Myelokathexis
    View official trial listing →
  • Not yet recruiting NCT NCT07792369

    26DT052; Scaling Busulfan Dose to Body Surface Area in Children

    Not yet reported Children's Hospital of Philadelphia 38 participants Est. completion 2031-09 1 site Stand-alone
    Other conditions: Busulfan Pharmacokinetic Analysis, Busulfan Dosing, Hematopoietic Stem Cell Transplant (HSCT), Busulfan, Glutathione
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Busulfan, Myleran, Busulfex

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.